{"metadata":{"kernelspec":{"name":"python3","display_name":"Python 3","language":"python"},"language_info":{"name":"python","version":"3.10.14","mimetype":"text/x-python","codemirror_mode":{"name":"ipython","version":3},"pygments_lexer":"ipython3","nbconvert_exporter":"python","file_extension":".py"},"colab":{"provenance":[],"toc_visible":true,"authorship_tag":"ABX9TyPVZ4pRXCpE4LFVF2nKXB7F"},"kaggle":{"accelerator":"none","dataSources":[],"dockerImageVersionId":30786,"isInternetEnabled":true,"language":"python","sourceType":"notebook","isGpuEnabled":false}},"nbformat_minor":4,"nbformat":4,"cells":[{"cell_type":"markdown","source":"##### Copyright 2025 Google LLC.","metadata":{}},{"cell_type":"code","source":"# @title Licensed under the Apache License, Version 2.0 (the \"License\");\n# you may not use this file except in compliance with the License.\n# You may obtain a copy of the License at\n#\n# https://www.apache.org/licenses/LICENSE-2.0\n#\n# Unless required by applicable law or agreed to in writing, software\n# distributed under the License is distributed on an \"AS IS\" BASIS,\n# WITHOUT WARRANTIES OR CONDITIONS OF ANY KIND, either express or implied.\n# See the License for the specific language governing permissions and\n# limitations under the License.","metadata":{"trusted":true,"execution":{"iopub.status.busy":"2025-04-22T13:55:11.344495Z","iopub.execute_input":"2025-04-22T13:55:11.344825Z","iopub.status.idle":"2025-04-22T13:55:11.370558Z","shell.execute_reply.started":"2025-04-22T13:55:11.344782Z","shell.execute_reply":"2025-04-22T13:55:11.369095Z"}},"outputs":[],"execution_count":1},{"cell_type":"code","source":"","metadata":{"trusted":true},"outputs":[],"execution_count":null},{"cell_type":"markdown","source":"# Project Title\n**AI-Powered Insights for Mental Health Drug Targets: Depression, Psychosis & Anxiety**\n\n","metadata":{"id":"u8QTQ5viA7S0"}},{"cell_type":"markdown","source":" # Problem Description","metadata":{}},{"cell_type":"markdown","source":"Mental health disorders such as depression, psychosis, and anxiety continue to pose serious global health challenges, especially in low-resource settings. Identifying potential biological drug targets is often limited by manual research workflows, fragmented literature, and time-consuming analysis.\n\nThis project aims to show a glimp of possiblity of how AI could be used to solve this by building an AI-powered research assistant that enables:\n\nRapid search through thousands of mental health-related scientific papers (PubMed is used as the focus in this project).\n\nInsight generation using Retrieval-Augmented Generation (RAG).\n\nContext-aware reasoning with agents for better drug target suggestions\n\nThis tool is built to assist mental health researchers and pharmaceutical teams in accelerating discovery and hypothesis generation for drug targets.","metadata":{}},{"cell_type":"code","source":"","metadata":{"trusted":true},"outputs":[],"execution_count":null},{"cell_type":"markdown","source":"## Set up the SDK","metadata":{"id":"GflcN2KzBIr3"}},{"cell_type":"code","source":"!pip uninstall -qqy jupyterlab kfp  # Remove unused conflicting packages\n!pip install -qU \"google-genai==1.7.0\" \"chromadb==0.6.3\"\n!pip install ipywidgets==7.7.2","metadata":{"id":"rRDDcLfmBIVs","execution":{"iopub.status.busy":"2025-04-22T13:55:11.434176Z","iopub.execute_input":"2025-04-22T13:55:11.434551Z","iopub.status.idle":"2025-04-22T13:56:04.627210Z","shell.execute_reply.started":"2025-04-22T13:55:11.434518Z","shell.execute_reply":"2025-04-22T13:56:04.626122Z"},"trusted":true},"outputs":[{"name":"stdout","text":"Collecting ipywidgets==7.7.2\n  Downloading ipywidgets-7.7.2-py2.py3-none-any.whl.metadata (1.9 kB)\nRequirement already satisfied: ipykernel>=4.5.1 in /opt/conda/lib/python3.10/site-packages (from ipywidgets==7.7.2) (6.29.4)\nRequirement already satisfied: ipython-genutils~=0.2.0 in /opt/conda/lib/python3.10/site-packages (from ipywidgets==7.7.2) (0.2.0)\nRequirement already satisfied: traitlets>=4.3.1 in /opt/conda/lib/python3.10/site-packages (from ipywidgets==7.7.2) (5.14.3)\nRequirement already satisfied: widgetsnbextension~=3.6.0 in /opt/conda/lib/python3.10/site-packages (from ipywidgets==7.7.2) (3.6.9)\nRequirement already satisfied: ipython>=4.0.0 in /opt/conda/lib/python3.10/site-packages (from ipywidgets==7.7.2) (8.21.0)\nCollecting jupyterlab-widgets<3,>=1.0.0 (from ipywidgets==7.7.2)\n  Downloading jupyterlab_widgets-1.1.11-py3-none-any.whl.metadata (3.7 kB)\nRequirement already satisfied: comm>=0.1.1 in /opt/conda/lib/python3.10/site-packages (from ipykernel>=4.5.1->ipywidgets==7.7.2) (0.2.2)\nRequirement already satisfied: debugpy>=1.6.5 in /opt/conda/lib/python3.10/site-packages (from ipykernel>=4.5.1->ipywidgets==7.7.2) (1.8.1)\nRequirement already satisfied: jupyter-client>=6.1.12 in /opt/conda/lib/python3.10/site-packages (from ipykernel>=4.5.1->ipywidgets==7.7.2) (7.4.9)\nRequirement already satisfied: jupyter-core!=5.0.*,>=4.12 in /opt/conda/lib/python3.10/site-packages (from ipykernel>=4.5.1->ipywidgets==7.7.2) (5.7.2)\nRequirement already satisfied: matplotlib-inline>=0.1 in /opt/conda/lib/python3.10/site-packages (from ipykernel>=4.5.1->ipywidgets==7.7.2) (0.1.7)\nRequirement already satisfied: nest-asyncio in /opt/conda/lib/python3.10/site-packages (from ipykernel>=4.5.1->ipywidgets==7.7.2) (1.6.0)\nRequirement already satisfied: packaging in /opt/conda/lib/python3.10/site-packages (from ipykernel>=4.5.1->ipywidgets==7.7.2) (21.3)\nRequirement already satisfied: psutil in /opt/conda/lib/python3.10/site-packages (from ipykernel>=4.5.1->ipywidgets==7.7.2) (5.9.3)\nRequirement already satisfied: pyzmq>=24 in /opt/conda/lib/python3.10/site-packages (from ipykernel>=4.5.1->ipywidgets==7.7.2) (26.0.3)\nRequirement already satisfied: tornado>=6.1 in /opt/conda/lib/python3.10/site-packages (from ipykernel>=4.5.1->ipywidgets==7.7.2) (6.4.1)\nRequirement already satisfied: decorator in /opt/conda/lib/python3.10/site-packages (from ipython>=4.0.0->ipywidgets==7.7.2) (5.1.1)\nRequirement already satisfied: jedi>=0.16 in /opt/conda/lib/python3.10/site-packages (from ipython>=4.0.0->ipywidgets==7.7.2) (0.19.1)\nRequirement already satisfied: prompt-toolkit<3.1.0,>=3.0.41 in /opt/conda/lib/python3.10/site-packages (from ipython>=4.0.0->ipywidgets==7.7.2) (3.0.47)\nRequirement already satisfied: pygments>=2.4.0 in /opt/conda/lib/python3.10/site-packages (from ipython>=4.0.0->ipywidgets==7.7.2) (2.18.0)\nRequirement already satisfied: stack-data in /opt/conda/lib/python3.10/site-packages (from ipython>=4.0.0->ipywidgets==7.7.2) (0.6.2)\nRequirement already satisfied: exceptiongroup in /opt/conda/lib/python3.10/site-packages (from ipython>=4.0.0->ipywidgets==7.7.2) (1.2.0)\nRequirement already satisfied: pexpect>4.3 in /opt/conda/lib/python3.10/site-packages (from ipython>=4.0.0->ipywidgets==7.7.2) (4.9.0)\nRequirement already satisfied: notebook>=4.4.1 in /opt/conda/lib/python3.10/site-packages (from widgetsnbextension~=3.6.0->ipywidgets==7.7.2) (6.5.7)\nRequirement already satisfied: parso<0.9.0,>=0.8.3 in /opt/conda/lib/python3.10/site-packages (from jedi>=0.16->ipython>=4.0.0->ipywidgets==7.7.2) (0.8.4)\nRequirement already satisfied: entrypoints in /opt/conda/lib/python3.10/site-packages (from jupyter-client>=6.1.12->ipykernel>=4.5.1->ipywidgets==7.7.2) (0.4)\nRequirement already satisfied: python-dateutil>=2.8.2 in /opt/conda/lib/python3.10/site-packages (from jupyter-client>=6.1.12->ipykernel>=4.5.1->ipywidgets==7.7.2) (2.9.0.post0)\nRequirement already satisfied: platformdirs>=2.5 in /opt/conda/lib/python3.10/site-packages (from jupyter-core!=5.0.*,>=4.12->ipykernel>=4.5.1->ipywidgets==7.7.2) (3.11.0)\nRequirement already satisfied: jinja2 in /opt/conda/lib/python3.10/site-packages (from notebook>=4.4.1->widgetsnbextension~=3.6.0->ipywidgets==7.7.2) (3.1.4)\nRequirement already satisfied: argon2-cffi in /opt/conda/lib/python3.10/site-packages (from notebook>=4.4.1->widgetsnbextension~=3.6.0->ipywidgets==7.7.2) (23.1.0)\nRequirement already satisfied: nbformat in /opt/conda/lib/python3.10/site-packages (from notebook>=4.4.1->widgetsnbextension~=3.6.0->ipywidgets==7.7.2) (5.10.4)\nRequirement already satisfied: nbconvert>=5 in /opt/conda/lib/python3.10/site-packages (from notebook>=4.4.1->widgetsnbextension~=3.6.0->ipywidgets==7.7.2) (6.4.5)\nRequirement already satisfied: Send2Trash>=1.8.0 in /opt/conda/lib/python3.10/site-packages (from notebook>=4.4.1->widgetsnbextension~=3.6.0->ipywidgets==7.7.2) (1.8.3)\nRequirement already satisfied: terminado>=0.8.3 in /opt/conda/lib/python3.10/site-packages (from notebook>=4.4.1->widgetsnbextension~=3.6.0->ipywidgets==7.7.2) (0.18.1)\nRequirement already satisfied: prometheus-client in /opt/conda/lib/python3.10/site-packages (from notebook>=4.4.1->widgetsnbextension~=3.6.0->ipywidgets==7.7.2) (0.20.0)\nRequirement already satisfied: nbclassic>=0.4.7 in /opt/conda/lib/python3.10/site-packages (from notebook>=4.4.1->widgetsnbextension~=3.6.0->ipywidgets==7.7.2) (1.1.0)\nRequirement already satisfied: ptyprocess>=0.5 in /opt/conda/lib/python3.10/site-packages (from pexpect>4.3->ipython>=4.0.0->ipywidgets==7.7.2) (0.7.0)\nRequirement already satisfied: wcwidth in /opt/conda/lib/python3.10/site-packages (from prompt-toolkit<3.1.0,>=3.0.41->ipython>=4.0.0->ipywidgets==7.7.2) (0.2.13)\nRequirement already satisfied: pyparsing!=3.0.5,>=2.0.2 in /opt/conda/lib/python3.10/site-packages (from packaging->ipykernel>=4.5.1->ipywidgets==7.7.2) (3.1.2)\nRequirement already satisfied: executing>=1.2.0 in /opt/conda/lib/python3.10/site-packages (from stack-data->ipython>=4.0.0->ipywidgets==7.7.2) (2.0.1)\nRequirement already satisfied: asttokens>=2.1.0 in /opt/conda/lib/python3.10/site-packages (from stack-data->ipython>=4.0.0->ipywidgets==7.7.2) (2.4.1)\nRequirement already satisfied: pure-eval in /opt/conda/lib/python3.10/site-packages (from stack-data->ipython>=4.0.0->ipywidgets==7.7.2) (0.2.2)\nRequirement already satisfied: six>=1.12.0 in /opt/conda/lib/python3.10/site-packages (from asttokens>=2.1.0->stack-data->ipython>=4.0.0->ipywidgets==7.7.2) (1.16.0)\nRequirement already satisfied: notebook-shim>=0.2.3 in /opt/conda/lib/python3.10/site-packages (from nbclassic>=0.4.7->notebook>=4.4.1->widgetsnbextension~=3.6.0->ipywidgets==7.7.2) (0.2.4)\nRequirement already satisfied: mistune<2,>=0.8.1 in /opt/conda/lib/python3.10/site-packages (from nbconvert>=5->notebook>=4.4.1->widgetsnbextension~=3.6.0->ipywidgets==7.7.2) (0.8.4)\nRequirement already satisfied: jupyterlab-pygments in /opt/conda/lib/python3.10/site-packages (from nbconvert>=5->notebook>=4.4.1->widgetsnbextension~=3.6.0->ipywidgets==7.7.2) (0.3.0)\nRequirement already satisfied: bleach in /opt/conda/lib/python3.10/site-packages (from nbconvert>=5->notebook>=4.4.1->widgetsnbextension~=3.6.0->ipywidgets==7.7.2) (6.1.0)\nRequirement already satisfied: pandocfilters>=1.4.1 in /opt/conda/lib/python3.10/site-packages (from nbconvert>=5->notebook>=4.4.1->widgetsnbextension~=3.6.0->ipywidgets==7.7.2) (1.5.0)\nRequirement already satisfied: testpath in /opt/conda/lib/python3.10/site-packages (from nbconvert>=5->notebook>=4.4.1->widgetsnbextension~=3.6.0->ipywidgets==7.7.2) (0.6.0)\nRequirement already satisfied: defusedxml in /opt/conda/lib/python3.10/site-packages (from nbconvert>=5->notebook>=4.4.1->widgetsnbextension~=3.6.0->ipywidgets==7.7.2) (0.7.1)\nRequirement already satisfied: beautifulsoup4 in /opt/conda/lib/python3.10/site-packages (from nbconvert>=5->notebook>=4.4.1->widgetsnbextension~=3.6.0->ipywidgets==7.7.2) (4.12.3)\nRequirement already satisfied: nbclient<0.6.0,>=0.5.0 in /opt/conda/lib/python3.10/site-packages (from nbconvert>=5->notebook>=4.4.1->widgetsnbextension~=3.6.0->ipywidgets==7.7.2) (0.5.13)\nRequirement already satisfied: MarkupSafe>=2.0 in /opt/conda/lib/python3.10/site-packages (from nbconvert>=5->notebook>=4.4.1->widgetsnbextension~=3.6.0->ipywidgets==7.7.2) (2.1.5)\nRequirement already satisfied: fastjsonschema>=2.15 in /opt/conda/lib/python3.10/site-packages (from nbformat->notebook>=4.4.1->widgetsnbextension~=3.6.0->ipywidgets==7.7.2) (2.19.1)\nRequirement already satisfied: jsonschema>=2.6 in /opt/conda/lib/python3.10/site-packages (from nbformat->notebook>=4.4.1->widgetsnbextension~=3.6.0->ipywidgets==7.7.2) (4.22.0)\nRequirement already satisfied: argon2-cffi-bindings in /opt/conda/lib/python3.10/site-packages (from argon2-cffi->notebook>=4.4.1->widgetsnbextension~=3.6.0->ipywidgets==7.7.2) (21.2.0)\nRequirement already satisfied: attrs>=22.2.0 in /opt/conda/lib/python3.10/site-packages (from jsonschema>=2.6->nbformat->notebook>=4.4.1->widgetsnbextension~=3.6.0->ipywidgets==7.7.2) (23.2.0)\nRequirement already satisfied: jsonschema-specifications>=2023.03.6 in /opt/conda/lib/python3.10/site-packages (from jsonschema>=2.6->nbformat->notebook>=4.4.1->widgetsnbextension~=3.6.0->ipywidgets==7.7.2) (2023.12.1)\nRequirement already satisfied: referencing>=0.28.4 in /opt/conda/lib/python3.10/site-packages (from jsonschema>=2.6->nbformat->notebook>=4.4.1->widgetsnbextension~=3.6.0->ipywidgets==7.7.2) (0.35.1)\nRequirement already satisfied: rpds-py>=0.7.1 in /opt/conda/lib/python3.10/site-packages (from jsonschema>=2.6->nbformat->notebook>=4.4.1->widgetsnbextension~=3.6.0->ipywidgets==7.7.2) (0.18.1)\nRequirement already satisfied: jupyter-server<3,>=1.8 in /opt/conda/lib/python3.10/site-packages (from notebook-shim>=0.2.3->nbclassic>=0.4.7->notebook>=4.4.1->widgetsnbextension~=3.6.0->ipywidgets==7.7.2) (2.12.5)\nRequirement already satisfied: cffi>=1.0.1 in /opt/conda/lib/python3.10/site-packages (from argon2-cffi-bindings->argon2-cffi->notebook>=4.4.1->widgetsnbextension~=3.6.0->ipywidgets==7.7.2) (1.16.0)\nRequirement already satisfied: soupsieve>1.2 in /opt/conda/lib/python3.10/site-packages (from beautifulsoup4->nbconvert>=5->notebook>=4.4.1->widgetsnbextension~=3.6.0->ipywidgets==7.7.2) (2.5)\nRequirement already satisfied: webencodings in /opt/conda/lib/python3.10/site-packages (from bleach->nbconvert>=5->notebook>=4.4.1->widgetsnbextension~=3.6.0->ipywidgets==7.7.2) (0.5.1)\nRequirement already satisfied: pycparser in /opt/conda/lib/python3.10/site-packages (from cffi>=1.0.1->argon2-cffi-bindings->argon2-cffi->notebook>=4.4.1->widgetsnbextension~=3.6.0->ipywidgets==7.7.2) (2.22)\nRequirement already satisfied: anyio>=3.1.0 in /opt/conda/lib/python3.10/site-packages (from jupyter-server<3,>=1.8->notebook-shim>=0.2.3->nbclassic>=0.4.7->notebook>=4.4.1->widgetsnbextension~=3.6.0->ipywidgets==7.7.2) (4.9.0)\nRequirement already satisfied: jupyter-events>=0.9.0 in /opt/conda/lib/python3.10/site-packages (from jupyter-server<3,>=1.8->notebook-shim>=0.2.3->nbclassic>=0.4.7->notebook>=4.4.1->widgetsnbextension~=3.6.0->ipywidgets==7.7.2) (0.10.0)\nRequirement already satisfied: jupyter-server-terminals in /opt/conda/lib/python3.10/site-packages (from jupyter-server<3,>=1.8->notebook-shim>=0.2.3->nbclassic>=0.4.7->notebook>=4.4.1->widgetsnbextension~=3.6.0->ipywidgets==7.7.2) (0.5.3)\nRequirement already satisfied: overrides in /opt/conda/lib/python3.10/site-packages (from jupyter-server<3,>=1.8->notebook-shim>=0.2.3->nbclassic>=0.4.7->notebook>=4.4.1->widgetsnbextension~=3.6.0->ipywidgets==7.7.2) (7.7.0)\nRequirement already satisfied: websocket-client in /opt/conda/lib/python3.10/site-packages (from jupyter-server<3,>=1.8->notebook-shim>=0.2.3->nbclassic>=0.4.7->notebook>=4.4.1->widgetsnbextension~=3.6.0->ipywidgets==7.7.2) (1.8.0)\nRequirement already satisfied: idna>=2.8 in /opt/conda/lib/python3.10/site-packages (from anyio>=3.1.0->jupyter-server<3,>=1.8->notebook-shim>=0.2.3->nbclassic>=0.4.7->notebook>=4.4.1->widgetsnbextension~=3.6.0->ipywidgets==7.7.2) (3.7)\nRequirement already satisfied: sniffio>=1.1 in /opt/conda/lib/python3.10/site-packages (from anyio>=3.1.0->jupyter-server<3,>=1.8->notebook-shim>=0.2.3->nbclassic>=0.4.7->notebook>=4.4.1->widgetsnbextension~=3.6.0->ipywidgets==7.7.2) (1.3.1)\nRequirement already satisfied: typing_extensions>=4.5 in /opt/conda/lib/python3.10/site-packages (from anyio>=3.1.0->jupyter-server<3,>=1.8->notebook-shim>=0.2.3->nbclassic>=0.4.7->notebook>=4.4.1->widgetsnbextension~=3.6.0->ipywidgets==7.7.2) (4.12.2)\nRequirement already satisfied: python-json-logger>=2.0.4 in /opt/conda/lib/python3.10/site-packages (from jupyter-events>=0.9.0->jupyter-server<3,>=1.8->notebook-shim>=0.2.3->nbclassic>=0.4.7->notebook>=4.4.1->widgetsnbextension~=3.6.0->ipywidgets==7.7.2) (2.0.7)\nRequirement already satisfied: pyyaml>=5.3 in /opt/conda/lib/python3.10/site-packages (from jupyter-events>=0.9.0->jupyter-server<3,>=1.8->notebook-shim>=0.2.3->nbclassic>=0.4.7->notebook>=4.4.1->widgetsnbextension~=3.6.0->ipywidgets==7.7.2) (6.0.2)\nRequirement already satisfied: rfc3339-validator in /opt/conda/lib/python3.10/site-packages (from jupyter-events>=0.9.0->jupyter-server<3,>=1.8->notebook-shim>=0.2.3->nbclassic>=0.4.7->notebook>=4.4.1->widgetsnbextension~=3.6.0->ipywidgets==7.7.2) (0.1.4)\nRequirement already satisfied: rfc3986-validator>=0.1.1 in /opt/conda/lib/python3.10/site-packages (from jupyter-events>=0.9.0->jupyter-server<3,>=1.8->notebook-shim>=0.2.3->nbclassic>=0.4.7->notebook>=4.4.1->widgetsnbextension~=3.6.0->ipywidgets==7.7.2) (0.1.1)\nRequirement already satisfied: fqdn in /opt/conda/lib/python3.10/site-packages (from jsonschema[format-nongpl]>=4.18.0->jupyter-events>=0.9.0->jupyter-server<3,>=1.8->notebook-shim>=0.2.3->nbclassic>=0.4.7->notebook>=4.4.1->widgetsnbextension~=3.6.0->ipywidgets==7.7.2) (1.5.1)\nRequirement already satisfied: isoduration in /opt/conda/lib/python3.10/site-packages (from jsonschema[format-nongpl]>=4.18.0->jupyter-events>=0.9.0->jupyter-server<3,>=1.8->notebook-shim>=0.2.3->nbclassic>=0.4.7->notebook>=4.4.1->widgetsnbextension~=3.6.0->ipywidgets==7.7.2) (20.11.0)\nRequirement already satisfied: jsonpointer>1.13 in /opt/conda/lib/python3.10/site-packages (from jsonschema[format-nongpl]>=4.18.0->jupyter-events>=0.9.0->jupyter-server<3,>=1.8->notebook-shim>=0.2.3->nbclassic>=0.4.7->notebook>=4.4.1->widgetsnbextension~=3.6.0->ipywidgets==7.7.2) (2.4)\nRequirement already satisfied: uri-template in /opt/conda/lib/python3.10/site-packages (from jsonschema[format-nongpl]>=4.18.0->jupyter-events>=0.9.0->jupyter-server<3,>=1.8->notebook-shim>=0.2.3->nbclassic>=0.4.7->notebook>=4.4.1->widgetsnbextension~=3.6.0->ipywidgets==7.7.2) (1.3.0)\nRequirement already satisfied: webcolors>=1.11 in /opt/conda/lib/python3.10/site-packages (from jsonschema[format-nongpl]>=4.18.0->jupyter-events>=0.9.0->jupyter-server<3,>=1.8->notebook-shim>=0.2.3->nbclassic>=0.4.7->notebook>=4.4.1->widgetsnbextension~=3.6.0->ipywidgets==7.7.2) (24.6.0)\nRequirement already satisfied: arrow>=0.15.0 in /opt/conda/lib/python3.10/site-packages (from isoduration->jsonschema[format-nongpl]>=4.18.0->jupyter-events>=0.9.0->jupyter-server<3,>=1.8->notebook-shim>=0.2.3->nbclassic>=0.4.7->notebook>=4.4.1->widgetsnbextension~=3.6.0->ipywidgets==7.7.2) (1.3.0)\nRequirement already satisfied: types-python-dateutil>=2.8.10 in /opt/conda/lib/python3.10/site-packages (from arrow>=0.15.0->isoduration->jsonschema[format-nongpl]>=4.18.0->jupyter-events>=0.9.0->jupyter-server<3,>=1.8->notebook-shim>=0.2.3->nbclassic>=0.4.7->notebook>=4.4.1->widgetsnbextension~=3.6.0->ipywidgets==7.7.2) (2.9.0.20240316)\nDownloading ipywidgets-7.7.2-py2.py3-none-any.whl (123 kB)\n\u001b[2K   \u001b[90m━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━\u001b[0m \u001b[32m123.4/123.4 kB\u001b[0m \u001b[31m3.0 MB/s\u001b[0m eta \u001b[36m0:00:00\u001b[0m00:01\u001b[0m\n\u001b[?25hDownloading jupyterlab_widgets-1.1.11-py3-none-any.whl (246 kB)\n\u001b[2K   \u001b[90m━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━\u001b[0m \u001b[32m246.9/246.9 kB\u001b[0m \u001b[31m9.9 MB/s\u001b[0m eta \u001b[36m0:00:00\u001b[0m\n\u001b[?25hInstalling collected packages: jupyterlab-widgets, ipywidgets\n  Attempting uninstall: jupyterlab-widgets\n    Found existing installation: jupyterlab_widgets 3.0.11\n    Uninstalling jupyterlab_widgets-3.0.11:\n      Successfully uninstalled jupyterlab_widgets-3.0.11\n  Attempting uninstall: ipywidgets\n    Found existing installation: ipywidgets 7.7.1\n    Uninstalling ipywidgets-7.7.1:\n      Successfully uninstalled ipywidgets-7.7.1\n\u001b[31mERROR: pip's dependency resolver does not currently take into account all the packages that are installed. This behaviour is the source of the following dependency conflicts.\nbigframes 0.22.0 requires google-cloud-bigquery[bqstorage,pandas]>=3.10.0, but you have google-cloud-bigquery 2.34.4 which is incompatible.\nbigframes 0.22.0 requires google-cloud-storage>=2.0.0, but you have google-cloud-storage 1.44.0 which is incompatible.\nbigframes 0.22.0 requires pandas<2.1.4,>=1.5.0, but you have pandas 2.2.3 which is incompatible.\ndataproc-jupyter-plugin 0.1.79 requires pydantic~=1.10.0, but you have pydantic 2.9.2 which is incompatible.\u001b[0m\u001b[31m\n\u001b[0mSuccessfully installed ipywidgets-7.7.2 jupyterlab-widgets-1.1.11\n","output_type":"stream"}],"execution_count":2},{"cell_type":"code","source":"!pip install Bio\n!pip install faiss-cpu","metadata":{"trusted":true,"execution":{"iopub.status.busy":"2025-04-22T13:56:04.629924Z","iopub.execute_input":"2025-04-22T13:56:04.630397Z","iopub.status.idle":"2025-04-22T13:56:28.858965Z","shell.execute_reply.started":"2025-04-22T13:56:04.630343Z","shell.execute_reply":"2025-04-22T13:56:28.857837Z"}},"outputs":[{"name":"stdout","text":"Collecting Bio\n  Downloading bio-1.7.1-py3-none-any.whl.metadata (5.7 kB)\nCollecting biopython>=1.80 (from Bio)\n  Downloading biopython-1.85-cp310-cp310-manylinux_2_17_x86_64.manylinux2014_x86_64.whl.metadata (13 kB)\nCollecting gprofiler-official (from Bio)\n  Downloading gprofiler_official-1.0.0-py3-none-any.whl.metadata (11 kB)\nCollecting mygene (from Bio)\n  Downloading mygene-3.2.2-py2.py3-none-any.whl.metadata (10 kB)\nRequirement already satisfied: pandas in /opt/conda/lib/python3.10/site-packages (from Bio) (2.2.3)\nRequirement already satisfied: pooch in /opt/conda/lib/python3.10/site-packages (from Bio) (1.8.2)\nRequirement already satisfied: requests in /opt/conda/lib/python3.10/site-packages (from Bio) (2.32.3)\nRequirement already satisfied: tqdm in /opt/conda/lib/python3.10/site-packages (from Bio) (4.66.4)\nRequirement already satisfied: numpy in /opt/conda/lib/python3.10/site-packages (from biopython>=1.80->Bio) (1.26.4)\nCollecting biothings-client>=0.2.6 (from mygene->Bio)\n  Downloading biothings_client-0.4.1-py3-none-any.whl.metadata (10 kB)\nRequirement already satisfied: python-dateutil>=2.8.2 in /opt/conda/lib/python3.10/site-packages (from pandas->Bio) (2.9.0.post0)\nRequirement already satisfied: pytz>=2020.1 in /opt/conda/lib/python3.10/site-packages (from pandas->Bio) (2024.1)\nRequirement already satisfied: tzdata>=2022.7 in /opt/conda/lib/python3.10/site-packages (from pandas->Bio) (2024.1)\nRequirement already satisfied: platformdirs>=2.5.0 in /opt/conda/lib/python3.10/site-packages (from pooch->Bio) (3.11.0)\nRequirement already satisfied: packaging>=20.0 in /opt/conda/lib/python3.10/site-packages (from pooch->Bio) (21.3)\nRequirement already satisfied: charset-normalizer<4,>=2 in /opt/conda/lib/python3.10/site-packages (from requests->Bio) (3.3.2)\nRequirement already satisfied: idna<4,>=2.5 in /opt/conda/lib/python3.10/site-packages (from requests->Bio) (3.7)\nRequirement already satisfied: urllib3<3,>=1.21.1 in /opt/conda/lib/python3.10/site-packages (from requests->Bio) (1.26.18)\nRequirement already satisfied: certifi>=2017.4.17 in /opt/conda/lib/python3.10/site-packages (from requests->Bio) (2024.8.30)\nRequirement already satisfied: httpx>=0.22.0 in /opt/conda/lib/python3.10/site-packages (from biothings-client>=0.2.6->mygene->Bio) (0.28.1)\nRequirement already satisfied: pyparsing!=3.0.5,>=2.0.2 in /opt/conda/lib/python3.10/site-packages (from packaging>=20.0->pooch->Bio) (3.1.2)\nRequirement already satisfied: six>=1.5 in /opt/conda/lib/python3.10/site-packages (from python-dateutil>=2.8.2->pandas->Bio) (1.16.0)\nRequirement already satisfied: anyio in /opt/conda/lib/python3.10/site-packages (from httpx>=0.22.0->biothings-client>=0.2.6->mygene->Bio) (4.9.0)\nRequirement already satisfied: httpcore==1.* in /opt/conda/lib/python3.10/site-packages (from httpx>=0.22.0->biothings-client>=0.2.6->mygene->Bio) (1.0.5)\nRequirement already satisfied: h11<0.15,>=0.13 in /opt/conda/lib/python3.10/site-packages (from httpcore==1.*->httpx>=0.22.0->biothings-client>=0.2.6->mygene->Bio) (0.14.0)\nRequirement already satisfied: exceptiongroup>=1.0.2 in /opt/conda/lib/python3.10/site-packages (from anyio->httpx>=0.22.0->biothings-client>=0.2.6->mygene->Bio) (1.2.0)\nRequirement already satisfied: sniffio>=1.1 in /opt/conda/lib/python3.10/site-packages (from anyio->httpx>=0.22.0->biothings-client>=0.2.6->mygene->Bio) (1.3.1)\nRequirement already satisfied: typing_extensions>=4.5 in /opt/conda/lib/python3.10/site-packages (from anyio->httpx>=0.22.0->biothings-client>=0.2.6->mygene->Bio) (4.12.2)\nDownloading bio-1.7.1-py3-none-any.whl (280 kB)\n\u001b[2K   \u001b[90m━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━\u001b[0m \u001b[32m281.0/281.0 kB\u001b[0m \u001b[31m5.8 MB/s\u001b[0m eta \u001b[36m0:00:00\u001b[0m00:01\u001b[0m\n\u001b[?25hDownloading biopython-1.85-cp310-cp310-manylinux_2_17_x86_64.manylinux2014_x86_64.whl (3.2 MB)\n\u001b[2K   \u001b[90m━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━\u001b[0m \u001b[32m3.2/3.2 MB\u001b[0m \u001b[31m51.5 MB/s\u001b[0m eta \u001b[36m0:00:00\u001b[0ma \u001b[36m0:00:01\u001b[0m\n\u001b[?25hDownloading gprofiler_official-1.0.0-py3-none-any.whl (9.3 kB)\nDownloading mygene-3.2.2-py2.py3-none-any.whl (5.4 kB)\nDownloading biothings_client-0.4.1-py3-none-any.whl (46 kB)\n\u001b[2K   \u001b[90m━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━\u001b[0m \u001b[32m46.7/46.7 kB\u001b[0m \u001b[31m2.8 MB/s\u001b[0m eta \u001b[36m0:00:00\u001b[0m\n\u001b[?25hInstalling collected packages: biopython, gprofiler-official, biothings-client, mygene, Bio\nSuccessfully installed Bio-1.7.1 biopython-1.85 biothings-client-0.4.1 gprofiler-official-1.0.0 mygene-3.2.2\nCollecting faiss-cpu\n  Downloading faiss_cpu-1.10.0-cp310-cp310-manylinux_2_28_x86_64.whl.metadata (4.4 kB)\nRequirement already satisfied: numpy<3.0,>=1.25.0 in /opt/conda/lib/python3.10/site-packages (from faiss-cpu) (1.26.4)\nRequirement already satisfied: packaging in /opt/conda/lib/python3.10/site-packages (from faiss-cpu) (21.3)\nRequirement already satisfied: pyparsing!=3.0.5,>=2.0.2 in /opt/conda/lib/python3.10/site-packages (from packaging->faiss-cpu) (3.1.2)\nDownloading faiss_cpu-1.10.0-cp310-cp310-manylinux_2_28_x86_64.whl (30.7 MB)\n\u001b[2K   \u001b[90m━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━\u001b[0m \u001b[32m30.7/30.7 MB\u001b[0m \u001b[31m58.9 MB/s\u001b[0m eta \u001b[36m0:00:00\u001b[0m:00:01\u001b[0m00:01\u001b[0m\n\u001b[?25hInstalling collected packages: faiss-cpu\nSuccessfully installed faiss-cpu-1.10.0\n","output_type":"stream"}],"execution_count":3},{"cell_type":"code","source":"from google import genai\nfrom google.genai import types\n\ngenai.__version__","metadata":{"id":"9Q5GpJkIBNyE","execution":{"iopub.status.busy":"2025-04-22T13:56:28.860752Z","iopub.execute_input":"2025-04-22T13:56:28.861224Z","iopub.status.idle":"2025-04-22T13:56:30.066187Z","shell.execute_reply.started":"2025-04-22T13:56:28.861170Z","shell.execute_reply":"2025-04-22T13:56:30.065202Z"},"trusted":true},"outputs":[{"execution_count":4,"output_type":"execute_result","data":{"text/plain":"'1.7.0'"},"metadata":{}}],"execution_count":4},{"cell_type":"markdown","source":"### Set up your API key\n\nTo run the following cell, your API key must be stored it in a [Kaggle secret](https://www.kaggle.com/discussions/product-feedback/114053) named `GOOGLE_API_KEY`.\n\nIf you don't already have an API key, you can grab one from [AI Studio](https://aistudio.google.com/app/apikey). You can find [detailed instructions in the docs](https://ai.google.dev/gemini-api/docs/api-key).\n\nTo make the key available through Kaggle secrets, choose `Secrets` from the `Add-ons` menu and follow the instructions to add your key or enable it for this notebook.","metadata":{"id":"3t1owWKbBCwc"}},{"cell_type":"code","source":"from kaggle_secrets import UserSecretsClient\n\nuser_secrets = UserSecretsClient()\nprint(user_secrets)","metadata":{"id":"B0GMitJlA3mE","execution":{"iopub.status.busy":"2025-04-22T13:56:30.067803Z","iopub.execute_input":"2025-04-22T13:56:30.068418Z","iopub.status.idle":"2025-04-22T13:56:30.080926Z","shell.execute_reply.started":"2025-04-22T13:56:30.068369Z","shell.execute_reply":"2025-04-22T13:56:30.079929Z"},"trusted":true},"outputs":[{"name":"stdout","text":"<kaggle_secrets.UserSecretsClient object at 0x7c52030efca0>\n","output_type":"stream"}],"execution_count":5},{"cell_type":"code","source":"from kaggle_secrets import UserSecretsClient\nsecret_label = \"my_day1_secret_access_key\"\nsecret_value = UserSecretsClient().get_secret(secret_label)","metadata":{"trusted":true,"execution":{"iopub.status.busy":"2025-04-22T13:56:30.083363Z","iopub.execute_input":"2025-04-22T13:56:30.083695Z","iopub.status.idle":"2025-04-22T13:56:30.210174Z","shell.execute_reply.started":"2025-04-22T13:56:30.083645Z","shell.execute_reply":"2025-04-22T13:56:30.209087Z"}},"outputs":[],"execution_count":6},{"cell_type":"markdown","source":"If you received an error response along the lines of `No user secrets exist for kernel id ...`, then you need to add your API key via `Add-ons`, `Secrets` **and** enable it.\n\n![Screenshot of the checkbox to enable GOOGLE_API_KEY secret](https://storage.googleapis.com/kaggle-media/Images/5gdai_sc_3.png)","metadata":{},"attachments":{"fc7f8b43-44ef-4760-9344-cc68946310a7.png":{"image/png":"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"}}},{"cell_type":"markdown","source":"### Explore available models\n\nYou will be using the [`embedContent`](https://ai.google.dev/api/embeddings#method:-models.embedcontent) API method to calculate batch embeddings in this guide. Find a model that supports it through the [`models.list`](https://ai.google.dev/api/models#method:-models.list) endpoint. You can also find more information about the embedding models on [the models page](https://ai.google.dev/gemini-api/docs/models/gemini#text-embedding).","metadata":{"id":"Sp_8uANnLlyb"}},{"cell_type":"markdown","source":"## Calculate similarity scores\n\nThis example embeds some variations on the pangram, `The quick brown fox jumps over the lazy dog`, including spelling mistakes and shortenings of the phrase. Another pangram and a somewhat unrelated phrase have been included for comparison.\n\nIn this task, you are going to use the embeddings to calculate similarity scores, so the `task_type` for these embeddings is `semantic_similarity`. Check out the [API reference](https://ai.google.dev/api/embeddings#v1beta.TaskType) for the full list of tasks.","metadata":{"id":"zmGec4TqLF5j"}},{"cell_type":"code","source":"!pip install sentence_transformers","metadata":{"trusted":true,"execution":{"iopub.status.busy":"2025-04-22T13:56:30.211594Z","iopub.execute_input":"2025-04-22T13:56:30.212534Z","iopub.status.idle":"2025-04-22T13:56:40.889216Z","shell.execute_reply.started":"2025-04-22T13:56:30.212486Z","shell.execute_reply":"2025-04-22T13:56:40.887909Z"}},"outputs":[{"name":"stdout","text":"Collecting sentence_transformers\n  Downloading sentence_transformers-4.1.0-py3-none-any.whl.metadata (13 kB)\nRequirement already satisfied: transformers<5.0.0,>=4.41.0 in /opt/conda/lib/python3.10/site-packages (from sentence_transformers) (4.45.1)\nRequirement already satisfied: tqdm in /opt/conda/lib/python3.10/site-packages (from sentence_transformers) (4.66.4)\nRequirement already satisfied: torch>=1.11.0 in /opt/conda/lib/python3.10/site-packages (from sentence_transformers) (2.4.0+cpu)\nRequirement already satisfied: scikit-learn in /opt/conda/lib/python3.10/site-packages (from sentence_transformers) (1.2.2)\nRequirement already satisfied: scipy in /opt/conda/lib/python3.10/site-packages (from sentence_transformers) (1.14.1)\nRequirement already satisfied: huggingface-hub>=0.20.0 in /opt/conda/lib/python3.10/site-packages (from sentence_transformers) (0.25.1)\nRequirement already satisfied: Pillow in /opt/conda/lib/python3.10/site-packages (from sentence_transformers) (10.3.0)\nRequirement already satisfied: typing_extensions>=4.5.0 in /opt/conda/lib/python3.10/site-packages (from sentence_transformers) (4.12.2)\nRequirement already satisfied: filelock in /opt/conda/lib/python3.10/site-packages (from huggingface-hub>=0.20.0->sentence_transformers) (3.15.1)\nRequirement already satisfied: fsspec>=2023.5.0 in /opt/conda/lib/python3.10/site-packages (from huggingface-hub>=0.20.0->sentence_transformers) (2024.6.1)\nRequirement already satisfied: packaging>=20.9 in /opt/conda/lib/python3.10/site-packages (from huggingface-hub>=0.20.0->sentence_transformers) (21.3)\nRequirement already satisfied: pyyaml>=5.1 in /opt/conda/lib/python3.10/site-packages (from huggingface-hub>=0.20.0->sentence_transformers) (6.0.2)\nRequirement already satisfied: requests in /opt/conda/lib/python3.10/site-packages (from huggingface-hub>=0.20.0->sentence_transformers) (2.32.3)\nRequirement already satisfied: sympy in /opt/conda/lib/python3.10/site-packages (from torch>=1.11.0->sentence_transformers) (1.12)\nRequirement already satisfied: networkx in /opt/conda/lib/python3.10/site-packages (from torch>=1.11.0->sentence_transformers) (3.3)\nRequirement already satisfied: jinja2 in /opt/conda/lib/python3.10/site-packages (from torch>=1.11.0->sentence_transformers) (3.1.4)\nRequirement already satisfied: numpy>=1.17 in /opt/conda/lib/python3.10/site-packages (from transformers<5.0.0,>=4.41.0->sentence_transformers) (1.26.4)\nRequirement already satisfied: regex!=2019.12.17 in /opt/conda/lib/python3.10/site-packages (from transformers<5.0.0,>=4.41.0->sentence_transformers) (2024.5.15)\nRequirement already satisfied: safetensors>=0.4.1 in /opt/conda/lib/python3.10/site-packages (from transformers<5.0.0,>=4.41.0->sentence_transformers) (0.4.5)\nRequirement already satisfied: tokenizers<0.21,>=0.20 in /opt/conda/lib/python3.10/site-packages (from transformers<5.0.0,>=4.41.0->sentence_transformers) (0.20.0)\nRequirement already satisfied: joblib>=1.1.1 in /opt/conda/lib/python3.10/site-packages (from scikit-learn->sentence_transformers) (1.4.2)\nRequirement already satisfied: threadpoolctl>=2.0.0 in /opt/conda/lib/python3.10/site-packages (from scikit-learn->sentence_transformers) (3.5.0)\nRequirement already satisfied: pyparsing!=3.0.5,>=2.0.2 in /opt/conda/lib/python3.10/site-packages (from packaging>=20.9->huggingface-hub>=0.20.0->sentence_transformers) (3.1.2)\nRequirement already satisfied: MarkupSafe>=2.0 in /opt/conda/lib/python3.10/site-packages (from jinja2->torch>=1.11.0->sentence_transformers) (2.1.5)\nRequirement already satisfied: charset-normalizer<4,>=2 in /opt/conda/lib/python3.10/site-packages (from requests->huggingface-hub>=0.20.0->sentence_transformers) (3.3.2)\nRequirement already satisfied: idna<4,>=2.5 in /opt/conda/lib/python3.10/site-packages (from requests->huggingface-hub>=0.20.0->sentence_transformers) (3.7)\nRequirement already satisfied: urllib3<3,>=1.21.1 in /opt/conda/lib/python3.10/site-packages (from requests->huggingface-hub>=0.20.0->sentence_transformers) (1.26.18)\nRequirement already satisfied: certifi>=2017.4.17 in /opt/conda/lib/python3.10/site-packages (from requests->huggingface-hub>=0.20.0->sentence_transformers) (2024.8.30)\nRequirement already satisfied: mpmath>=0.19 in /opt/conda/lib/python3.10/site-packages (from sympy->torch>=1.11.0->sentence_transformers) (1.3.0)\nDownloading sentence_transformers-4.1.0-py3-none-any.whl (345 kB)\n\u001b[2K   \u001b[90m━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━\u001b[0m \u001b[32m345.7/345.7 kB\u001b[0m \u001b[31m5.6 MB/s\u001b[0m eta \u001b[36m0:00:00\u001b[0ma \u001b[36m0:00:01\u001b[0m\n\u001b[?25hInstalling collected packages: sentence_transformers\nSuccessfully installed sentence_transformers-4.1.0\n","output_type":"stream"}],"execution_count":7},{"cell_type":"code","source":"from Bio import Entrez\nimport nltk\nimport re\n\nfrom nltk.tokenize import sent_tokenize\n# Download the necessary Punkt data for tab-separated values\nnltk.download('punkt_tab')\nnltk.download('punkt')\n\nimport numpy as np\nfrom sentence_transformers import SentenceTransformer\n\nimport google.generativeai as genai\nimport faiss\nimport pandas as pd\nfrom sentence_transformers import SentenceTransformer\nimport os","metadata":{"trusted":true,"execution":{"iopub.status.busy":"2025-04-22T13:56:40.890886Z","iopub.execute_input":"2025-04-22T13:56:40.891247Z","iopub.status.idle":"2025-04-22T13:57:03.520507Z","shell.execute_reply.started":"2025-04-22T13:56:40.891203Z","shell.execute_reply":"2025-04-22T13:57:03.519538Z"}},"outputs":[{"name":"stdout","text":"[nltk_data] Downloading package punkt_tab to /usr/share/nltk_data...\n[nltk_data]   Unzipping tokenizers/punkt_tab.zip.\n[nltk_data] Downloading package punkt to /usr/share/nltk_data...\n[nltk_data]   Package punkt is already up-to-date!\n","output_type":"stream"}],"execution_count":8},{"cell_type":"markdown","source":"","metadata":{}},{"cell_type":"markdown","source":"#### Data Gathering & Preprocessing\nWe use the Entrez API to fetch numerous PubMed abstracts related to \"drug targets for depression, psychosis, and anxiety\". Each abstract is pre-cleaned and chunked into digestible text pieces.","metadata":{}},{"cell_type":"code","source":"\n# Configure Entrez email\nEntrez.email = \"abiodunadebisi614@gmail.com\"  \n\n# Search and fetch PubMed abstracts related to mental health disorders\ndef fetch_pubmed_abstracts(query, max_results=10):\n    handle = Entrez.esearch(db=\"pubmed\", term=query, retmax=max_results)\n    record = Entrez.read(handle)\n    id_list = record[\"IdList\"]\n    handle.close()\n\n    abstracts = []\n    if id_list:\n        handle = Entrez.efetch(db=\"pubmed\", id=\",\".join(id_list), rettype=\"abstract\", retmode=\"text\")\n        abstracts = handle.read().split(\"\\n\\n\")\n        handle.close()\n    return abstracts\n\n# Fetch sample data\nabstracts = fetch_pubmed_abstracts(\"depression OR psychosis OR anxiety\")\nlen(abstracts), abstracts[:2]\n    ","metadata":{"trusted":true,"execution":{"iopub.status.busy":"2025-04-22T13:57:03.521905Z","iopub.execute_input":"2025-04-22T13:57:03.523311Z","iopub.status.idle":"2025-04-22T13:57:04.155154Z","shell.execute_reply.started":"2025-04-22T13:57:03.523258Z","shell.execute_reply":"2025-04-22T13:57:04.154180Z"}},"outputs":[{"execution_count":9,"output_type":"execute_result","data":{"text/plain":"(67,\n ['1. Subst Use Misuse. 2025 Apr 22:1-10. doi: 10.1080/10826084.2025.2495781. Online\\n ahead of print.',\n  'The Impact of Timing of Alcohol Consumption on Implicit Drinking Identity Among \\nCollege Students with Heavy Episodic Drinking: The Role of Social Anxiety.'])"},"metadata":{}}],"execution_count":9},{"cell_type":"code","source":"def clean_text(text):\n    text = re.sub(r\"\\n\", \" \", text)\n    text = re.sub(r\"[^a-zA-Z0-9.,;:!?()\\-\\s]\", \"\", text)\n    text = re.sub(r\"\\s+\", \" \", text)\n    return text.strip()\n\ncleaned_abstracts = [clean_text(abs) for abs in abstracts if abs.strip()]\ncleaned_abstracts","metadata":{"trusted":true,"execution":{"iopub.status.busy":"2025-04-22T13:57:04.156636Z","iopub.execute_input":"2025-04-22T13:57:04.157098Z","iopub.status.idle":"2025-04-22T13:57:04.170451Z","shell.execute_reply.started":"2025-04-22T13:57:04.157052Z","shell.execute_reply":"2025-04-22T13:57:04.169177Z"}},"outputs":[{"execution_count":10,"output_type":"execute_result","data":{"text/plain":"['1. Subst Use Misuse. 2025 Apr 22:1-10. doi: 10.108010826084.2025.2495781. Online ahead of print.',\n 'The Impact of Timing of Alcohol Consumption on Implicit Drinking Identity Among College Students with Heavy Episodic Drinking: The Role of Social Anxiety.',\n 'Scherzer CR(1), Sullivan J(2), Buckner JD(1).',\n 'Author information: (1)Department of Psychology, Louisiana State University, Baton Rouge, LO, USA. (2)Department of Political Science, Louisiana State University, Baton Rouge, Louisiana, USA.',\n 'Background: College students with high trait social anxiety and heavy episodic drinking appear to consume greater quantity of alcohol, presumably because individuals with higher trait social anxiety may be more responsive to the stress-response dampening effects of alcohol in social contexts due to appraisal disruption. Yet little research has tested the impact of appraisal disruption on implicit social cognitions relevant to drinking behaviors among individuals with higher vs lower social anxiety. The current study tested whether the sequence of alcohol consumption and induction of an anticipatory social stressor interacts with trait social anxiety to predict changes in implicit drinking identity and implicit self-esteem. Methods: Undergraduate students who endorsed past-month heavy episodic drinking (N 51) received a dosage of alcohol and a social stressor. Participants were randomly assigned to receive alcohol prior to or after the social stressor. Results: There was a significant interaction between condition and trait social anxiety on changes in implicit drinking identity, such that alcohol consumption before induction of anticipatory anxiety (versus after) was associated with greater increases in implicit drinking identity among those with higher (but not lower) trait social anxiety. Conclusions: Findings shed light on the role of appraisal disruption on implicit drinking identity among college students with high social anxiety who endorse heavy episodic drinking, such that appraisal disruption is associated with greater increases in implicit drinking identity among students with high social anxiety. Counter to hypothesis, appraisal disruption did not impact implicit self-esteem, suggesting this effect may be specific to implicit drinking identity.',\n 'DOI: 10.108010826084.2025.2495781 PMID: 40260665',\n '2. CNS Neurosci Ther. 2025 Apr;31(4):e70353. doi: 10.1111cns.70353.',\n 'Therapeutic Targets and Molecular Mechanisms of Calycosin in the Treatment of Depression: Insights From Chronic Mild Stress Animal Models.',\n 'Gong G(1)(2), Liu Y(2), Zhang Z(2), Zheng Y(2).',\n 'Author information: (1)Department of Bioengineering, Zunyi Medical University, Zhuhai, Guangdong, China. (2)Guangdong Key Laboratory for Functional Substances in Medicinal Edible Resources and Healthcare Products, School of Life Sciences and Food Engineering, Hanshan Normal University, Chaozhou, Guangdong, China.',\n 'BACKGROUND: Depression is a complex psychiatric disorder with limited therapeutic options and various side effects. Calycosin, a bioactive compound derived from Astragalus membranaceus, possesses multiple pharmacological properties. This study aimed to investigate the antidepressant effects of calycosin in chronic mild stress (CMS) animal models of depression and to elucidate its underlying mechanisms. METHODS: The antidepressant effects of calycosin were assessed in vivo using CMS animal models of depression, including the grooming frequency test, sucrose intake test, tail suspension test, and open field test. Neurogenic effects were evaluated by measuring the levels of BDNF, GDNF, and NGF in isolated hippocampus tissues. The hepatoprotective effects were assessed by measuring liver enzyme levels. The molecular mechanisms underlying calycosins antidepressant effects were explored in vitro using PC12 cells. RESULTS: Calycosin exhibited potent antidepressant-like activities in CMS animal models of depression. Treatment with calycosin significantly alleviated depressive symptoms and improved neurogenic effects. Additionally, calycosin displayed hepatoprotective effects by modulating liver enzymes in vitro. The antidepressant effects of calycosin are mediated by the stimulation of the TrkB-MEK-Erk12-CREB signaling pathway. CONCLUSION: In conclusion, calycosin shows promise as a novel therapeutic agent for depression due to its potent antidepressant-like activities and diverse pharmacological properties. Further studies are warranted to elucidate the exact molecular targets of calycosin and to assess its efficacy and safety in clinical settings.',\n '2025 The Author(s). CNS Neuroscience Therapeutics published by John Wiley Sons Ltd.',\n 'DOI: 10.1111cns.70353 PMID: 40260589 Indexed for MEDLINE',\n '3. Personal Ment Health. 2025 May;19(2):e70019. doi: 10.1002pmh.70019.',\n 'Symptom Overlap Between Depression and Borderline Personality Disorder: A Network Analysis.',\n 'Kew BM(1), Monk NJ(1), Conner TS(2), Frampton C(1), Mulder RT(1), Porter RJ(1), Carter JD(3), Jordan J(1), McIntosh VVW(3), Douglas KM(1).',\n 'Author information: (1)Department of Psychological Medicine, University of Otago, Christchurch, New Zealand. (2)Department of Psychology, University of Otago, Dunedin, New Zealand. (3)School of Psychology, Speech and Hearing, University of Canterbury, Christchurch, New Zealand.',\n 'Major depression (MD) is a serious mental health disorder projected to become the leading cause of global disability by 2030. Borderline personality disorder (BPD) frequently co-occurs with MD. Individuals with both conditions often experience prolonged recovery times and exhibit high levels of suicidal behaviour. Network theory and its application, network analysis, presents a novel framework for conceptualising and understanding the comorbidity between MD and BPD. This network analysis aims to identify influential symptoms within a BPDMD network and explore the clinical relevance of these relationships. Data from 548 participants were pooled from four clinical trials run between 1994 and 2013 at the Department of Psychological Medicine, University of Otago, Christchurch, New Zealand. All participants were diagnosed with current MD (as part of major depressive disorder or bipolar II disorder). Baseline MD and BPD symptom data from trial entry assessments were entered into a cross-sectional network analysis. A further network analysis was estimated with the addition of three covariates (age, gender and depression severity) alongside the MD and BPD symptoms. Network analyses identified several connecting symptoms between MD and BPD. After controlling for depression severity, BPD symptoms of identity disturbance and unstable relationships had unique and robust relationships with MD suicidal ideation and behaviours. Further exploration of these bridge relationships found that participants who exhibited identity disturbance were almost three times more likely to have reported a previous suicide attempt. Results from this study have implications for risk assessment and treatment of individuals with comorbid MD and BPD.',\n '2025 The Authors Personality and Mental Health Published by John Wiley Sons Ltd.',\n 'DOI: 10.1002pmh.70019 PMID: 40260579 Indexed for MEDLINE',\n '4. Palliat Support Care. 2025 Apr 22;23:e98. doi: 10.1017S1478951525000355.',\n 'Cognitive interviewing of the older adults with cancer - depression scale (OAC-D): A patient-reported outcome (PRO).',\n 'Saracino RM(1), Polacek LC(1), Tutino R(1), Pessin H(1), Lynch KA(1), Atkinson TM(1), Nelson CJ(1).',\n 'Author information: (1)Department of Psychiatry Behavioral Sciences, Memorial Sloan Kettering Cancer Center, New York, NY, USA.',\n 'OBJECTIVES: This study aimed to refine the content of a new patient-reported outcome (PRO) measure via cognitive interviewing techniques to assess the unique presentation of depressive symptoms in older adults with cancer (OACs). METHODS: OACs ( 70years) with a history of a depressive disorder were administered a draft measure of the Older Adults with Cancer - Depression (OAC-D) Scale, then participated in a semi-structured cognitive interview to provide feedback on the appropriateness, comprehensibility, and overall acceptability of measure. Interviews were audio-recorded and transcribed, and qualitative methods guided revision of scale content and structure. RESULTS: OACs (N 10) with a range of cancer diagnoses completed cognitive interviews. Participants felt that the draft measure took a reasonable amount of time to answer and was easily understandable. They favored having item prompts and response anchors repeated with each item for ease of completion, and they helped identify phrasing and wording of key terms consistent with the authors intended constructs. From this feedback, a revised version of the OAC-D was created. SIGNIFICANCE OF RESULTS: The OAC-D Scale is the first PRO developed specifically for use with OACs. The use of expert and patient input and rigorous cognitive interviewing methods provides a conceptually accurate means of assessing the unique symptom experience of OACs with depression.',\n 'DOI: 10.1017S1478951525000355 PMID: 40260490 Indexed for MEDLINE',\n '5. Palliat Support Care. 2025 Apr 22;23:e97. doi: 10.1017S1478951525000252.',\n 'Accurate prognostic awareness is associated with increased emotional distress in Latino patients with advanced cancer.',\n 'Prez-Cruz PE(1)(2), San Martn MJ(3), Palacios J(4), Tupper-Satt L(5), Gonzlez-Otaza M(5), Repetto P(2)(6).',\n 'Author information: (1)Seccin de Medicina Paliativa, Facultad de Medicina, Pontificia Universidad Catlica de Chile, Santiago, Chile. (2)Centro para el Control y la Prevencin del Cncer (CECAN), Pontificia Universidad Catlica de Chile, Santiago, Chile. (3)Escuela de Psicologa, Facultad de Educacin, Psicologa y Familia, Universidad Finis Terrae, Santiago, Chile. (4)Programa de Medicina Paliativa y Cuidados Continuos, Facultad de Medicina, Pontificia Universidad Catlica de Chile, Santiago, Chile. (5)Unidad de Cuidados Paliativos, Complejo Asistencial Dr. Stero del Ro, Servicio de Salud Metropolitano Sur Oriente, Puente Alto, Chile. (6)Escuela de Psicologa, Pontificia Universidad Catlica de Chile, Santiago, Chile.',\n 'OBJECTIVES: To describe the frequency of prognostic awareness (PA) in a population of advanced cancer patients in a Latino community and to explore the relationship between accurate PA with emotional distress and other covariates. METHODS: In this cross-sectional study performed in Puente Alto, Chile, advanced cancer patients in palliative care completed a survey that included a single question to assess PA (Do you believe your cancer is curable? yesno). Patients reporting that their cancer was not curable were considered as having accurate PA. Demographics, emotional distress, quality of life, and patient perception of treatment goals were also assessed. Analyses to explore associations between PA and patient variables were adjusted. RESULTS: A total of 201 patients were included in the analysis. Mean age was 65, 50 female. One hundred and three patients (51) reported an accurate PA. In the univariate analysis, accurate PA was associated with not having a partner (p 0.012), increased emotional distress (p 0.013), depression (p 0.003), and were less likely to report that the goal of the treatment was to get rid of the cancer (p 0.001). In the multivariate analysis, patients with accurate PA had higher emotional distress or depression, were less likely to have a partner, and to report that the goal of the treatment was to get rid of the cancer. SIGNIFICANCE OF RESULTS: Half of a population of Latino advanced cancer patients reported an accurate PA. Accurate PA was associated with increased emotional distress, which is similar to what has been reported in other countries. Weaknesses in prognostic disclosure by clinicians, local cultural factors, or higher motivation to seek prognostic information among distressed cancer patients could explain this association. Strategies to emotionally support patients when discussing prognostic information should be implemented.',\n 'DOI: 10.1017S1478951525000252 PMID: 40260487 Indexed for MEDLINE',\n '6. J Alzheimers Dis. 2025 Apr 22:13872877251333155. doi: 10.117713872877251333155. Online ahead of print.',\n 'Virtual group singing programs for well-being in healthy older adults and persons with neurocognitive disorders during early COVID-19 pandemic: A perspective from Chicago.',\n 'Bonakdarpour B(1)(2)(3), Schafer R(4), Takarabe C(1)(2)(3), Barbieri E(1), Miller J(4), Miller SS(4).',\n 'Author information: (1)Mesulam Center for Cognitive Neurology and Alzheimers Disease, Chicago, IL, USA. (2)Northwestern Music and Medicine Program, Chicago, IL, USA. (3)Feinberg School of Medicine, Northwestern University, Chicago, IL, USA. (4)Sounds Good Choir, NFP, Downers Grove, IL, USA.',\n 'BackgroundDuring the COVID-19 pandemic, older adults experienced health declines due to isolation. Group singing is known to enhance social, emotional, and physical well-being, but its feasibility in virtual formats was unclear.ObjectiveTo assess the feasibility of virtual group singing for cognitively healthy (CH) adults and individuals with neurocognitive disorders (NcD) during the pandemic.MethodTwo teleconferencing programs were conducted for participants aged 55: (1) a sing-along series with 52 weekly sessions of familiar music and (2) a choir program with structured weekly rehearsals culminating in a virtual concert. Retrospective surveys assessed anxiety reduction, social connection, and physical well-being using Likert scales and participants provided open-ended responses. Quantitative data were analyzed with ordinal regression and probability modeling, while qualitative themes were explored with Fishers exact test.ResultsParticipants reported high levels of satisfaction across all measures. Sing-along programs provided greater satisfaction, particularly through reminiscence (p 0.003). Choir participants noted enhanced intellectual well-being (p 0.017). NcD participants were less satisfied with social connection but showed similar overall satisfaction levels compared to CH participants.ConclusionsVirtual group singing was feasible during periods of isolation as supported by satisfaction of the participants with pertaining to anxiety reduction, social connection and physical well-being. Sing-along programs provided emotional satisfaction through reminiscence (connection to past), while choir programs offered intellectual stimulation through multiple rehearsals. These findings highlight the potential of virtual singing to promote stability, connection, and well-being for older adults during times of disruption.',\n 'DOI: 10.117713872877251333155 PMID: 40260486',\n '7. JBI Evid Synth. 2025 Apr 21. doi: 10.11124JBIES-24-00166. Online ahead of print.',\n 'Experiences of health professionals in screening for postpartum depressive symptoms: a qualitative systematic review.',\n 'Brito APA(1)(2), Silva CM(3), Riesco ML(2)(3), Lima MOP(2)(4), McArthur A(5).',\n 'Author information: (1)Department of Nursing, University Hospital, University of So Paulo, So Paulo, SP, Brazil. (2)The Brazilian Centre for Evidence-based Healthcare: A JBI Centre of Excellence, University of So Paulo, So Paulo, SP, Brazil. (3)School of Nursing, University of So Paulo, So Paulo, SP, Brazil. (4)School of Arts, Science and Humanities, University of So Paulo, So Paulo, SP, Brazil. (5)JBI, Faculty of Health and Medical Sciences, The University of Adelaide, Adelaide, SA, Australia.',\n 'OBJECTIVE: The objective of this review is to assess and synthesize the available qualitative evidence on health professionals experiences in screening for postpartum depression (PPD). INTRODUCTION: PPD is a significant public health problem. Clinical screening is essential to develop appropriate interventions to meet the needs of women and their families. The findings of this review have important implications for decision-making and policy development for continuous professional development programs that promote evidence-based PPD screening. INCLUSION CRITERIA: This review considered studies that explore the experiences of health professionals who screen for PPD in any geographic location at any health care facility, scenario, or setting. The review focused on qualitative data, including methods such as phenomenology, grounded theory, ethnography, action research, and feminist research. METHODS: The review followed a 3-step search strategy in line with JBI methodology for systematic reviews of qualitative evidence. The databases searched included PubMed, CINAHL (EBSCOhost), Embase (Elsevier), Scopus, LILACS (BVS), ScienceDirect (Elsevier), PsycINFO (Ovid), Index Psi Journals (BVS-PSI), and PePsic (IPUSP). Unpublished studies were searched for in Google Scholar, Cybertesis, Dart-E, EthOS, and Open Access Theses and Dissertations (OATD). Two independent reviewers evaluated the included studies for methodological quality and extracted data using the JBI data extraction and synthesis tools. Studies published in English, Portuguese, and Spanish from database inception until October 2023 were included. RESULTS: Twenty-four qualitative studies from 14 countries across 5 continents involving 392 health professionals were included. A total of 113 findings were extracted and grouped into 5 categories: i) education and training; ii) responsibility of PPD screening, referral, and follow-up: role of the job and work overload; iii) screening, referral, and follow-up; iv) disclosure, judgment, culture; v) and health system structure. Two synthesized findings evolved from these categories: i) The need for training and ongoing education, professional role, professional practice, and ways of caring in screening postpartum women for depressive symptoms; ii) External barriers, facilitating factors, and health system issues. CONCLUSIONS: Health professionals experiences caring for women and families concerning PPD are influenced by their culture, practices, training, and worldview. Regular workshops and practical training sessions that emphasize the development of PPD-screening skills, particularly in recognizing subtle signs of depression and conducting culturally sensitive assessments, could be highly effective for health professionals. Policymakers should collaborate with health care professionals to develop and implement policies tailored to different contexts and cultures. Providing educational subsidies and ensuring monitoring and follow-up after PPD screening are fundamental for the sustainability of PPD screening and management.',\n 'Copyright 2025 JBI.',\n 'DOI: 10.11124JBIES-24-00166 PMID: 40260475',\n 'Conflict of interest statement: The authors declare no conflict of interest.',\n '8. Eur J Anaesthesiol. 2025 Apr 22. doi: 10.1097EJA.0000000000002180. Online ahead of print.',\n 'Factors influencing the choice of lumbar epidural analgesia and its association with postpartum depression risk.',\n 'Asif S(1), Kollia N, Kollmann A, Birgisdottir B, White RA, Lipcsey M, Skalkidou A.',\n 'Author information: (1)From the Department of Anesthesiology and Intensive Care Medicine, Department of Surgical Sciences (SA, AK, BB, ML), the Department of Womens and Childrens Health, Uppsala University, Uppsala, Sweden (NK, AS), the Department of Infection Control and Vaccines, Norwegian Institute of Public Health, Oslo, Norway (RAW), the Hedenstierna Laboratory, Department of Surgical Sciences, Uppsala University, Uppsala, Sweden (ML).',\n 'BACKGROUND: The use of lumbar epidural analgesia (LEA) during childbirth varies significantly among women. Factors influencing a womans choice of LEA and its possible effects on postpartum depression (PPD) remain underexplored. OBJECTIVES: To investigate factors influencing the choice of LEA among women with intended vaginal deliveries. A secondary objective was to explore the association between LEA use and PPD. STUDY DESIGN: A longitudinal cohort study. SETTING: Uppsala University Hospital, Sweden, 2010 to 2019. POPULATION: Women with an intended vaginal delivery. EXCLUSIONS: Twins, elective caesarean section, induction of labour. METHODS: Data were collected by web-based self-completed questionnaires at gestational weeks 17, 32 and at 6 weeks and 6 months postpartum. The exposures were sociodemographic, resilience-related, medical and obstetric characteristics of all participants from the BASIC (Biology, Affect, Stress, Imaging and Cognition) study. Information on the use of LEA was retrieved from medical records. PPD was assessed using either the Edinburgh Postnatal Depression Scale, or the Depression Self-Rating Scale, andor the Mini-International Neuropsychiatric Interview at 6 to 8 weeks and 6 months postpartum. Bayesian models were applied to investigate the associations of multivariate factors with the choice for LEA, and the association between the use of LEA and PPD. RESULTS: Among 4436 participants, 38 opted for LEA, while 62 did not. LEA users were younger, primiparous, reported higher rates of intimate partner violence (IPV) and had lower resilience. The adjusted model revealed primiparity, previous caesarean section, IPV, pregnancy length at least 280 days and fear of childbirth as independent predictors of LEA use. While LEA use was associated with higher odds of PPD in the crude regression model, it was no longer statistically significant after adjusting for possible confounders and mediators. CONCLUSION: Social and psychological vulnerabilities influence a womans decision to opt for LEA during childbirth. LEA was not associated with PPD in adjusted models. TRIAL REGISTRATION: This is a longitudinal study which was not registered back in 2010.',\n 'Copyright 2025 European Society of Anaesthesiology and Intensive Care. Unauthorized reproduction of this article is prohibited.',\n 'DOI: 10.1097EJA.0000000000002180 PMID: 40260465',\n '9. Span J Psychol. 2025 Apr 22;28:e11. doi: 10.1017SJP.2025.11.',\n 'Subclinically Depressed Individuals Showed Less Trust after a Night of Sleep Deprivation.',\n 'Li C(1), Lam YC(1), Hsiao JH(2), Yee LTS(3), Zhang J(4), Lau EYY(1)(2).',\n 'Author information: (1)The Education University of Hong Kong, China. (2)Hong Kong University of Science Technology, China. (3)University of Reading, UK. (4)Stanford University, USA.',\n 'Insufficient sleeps impact on cognitive and emotional function is well-documented, but its effects on social functioning remain understudied. This research investigates the influence of depressive symptoms on the relationship between sleep deprivation (SD) and social decision-making. Forty-two young adults were randomly assigned to either the SD or sleep control (SC) group. The SD group stayed awake in the laboratory, while the SC group had a normal nights sleep at home. During the subsequent morning, participants completed a Trust Game (TG) in which a higher monetary offer distributed by them indicated more trust toward their partners. They also completed an Ultimatum Game (UG) in which a higher acceptance rate indicated more rational decision-making. The results revealed that depressive symptoms significantly moderated the effect of SD on trust in the TG. However, there was no interaction between group and depressive symptoms found in predicting acceptance rates in the UG. This study demonstrates that individuals with higher levels of depressive symptoms display less trust after SD, highlighting the role of depressive symptoms in modulating the impact of SD on social decision-making. Future research should explore sleep-related interventions targeting the psychosocial dysfunctions of individuals with depression.',\n 'DOI: 10.1017SJP.2025.11 PMID: 40260462 Indexed for MEDLINE',\n '10. Clin Epidemiol. 2025 Apr 16;17:387-407. doi: 10.2147CLEP.S509147. eCollection 2025.',\n 'Mental Disorders in Danish Hospital Registers: A Review of Content and Possibilities for Epidemiological Research.',\n 'Plana-Ripoll O(1)(2), Liu X(2), Khler-Forsberg O(3)(4), Srensen HT(1), Momen NC(5).',\n 'Author information: (1)Department of Clinical Epidemiology, Center for Population Medicine, Aarhus University and Aarhus University Hospital, Aarhus, Denmark. (2)National Centre for Register-based Research, Department of Public Health, Aarhus University, Aarhus, Denmark. (3)Department of Clinical Medicine, Aarhus University, Aarhus, Denmark. (4)Psychosis Research Unit, Aarhus University Hospital Psychiatry, Aarhus, Denmark. (5)Department of Clinical Epidemiology, Aarhus University and Aarhus University Hospital, Aarhus, Denmark.',\n 'BACKGROUND: The Danish national hospital registers are a rich source of data for psychiatric epidemiology. The potential to identify diagnosed mental disorders in the Danish population has resulted in a plethora of important research studies. However, no recent review of these research sources exists. OBJECTIVE: To review the content, data quality and epidemiological considerations regarding mental disorders in the Danish hospital registers. METHODS: We provide information on the setting, history, and data access regarding mental disorders in the Danish hospital registers (defined according to the International Classification of Diseases, Tenth Revision, F group Mental and behavioural disorder codes). We describe the registration of mental disorders over time in the Danish hospital registers, by providing counts of individuals diagnosed with mental disorders each year, by types of mental disorders, diagnosis, hospital contact, and contact unit. We also provide information on considerations when using these data sources, including data quality. For this, we searched PubMed to identify validation studies of coding of mental disorder diagnoses. RESULTS: Between 1969 and 2022, 1,136,280 individuals (10.7 of all individuals who resided in Denmark in this period) have been registered as having a mental disorder as a primary or secondary diagnosis in a psychiatric unit in Denmark at least once. The type of contact and unit diagnoses were made in varied by mental disorder type. The literature indicates that a large proportion of coded diagnoses in the Danish hospital registers of mental disorders were considered valid. CONCLUSION: We provide an overview of the available data for investigating mental disorders in the Danish hospital registers. We raise awareness of the limitations researchers should be aware of when using this data and discuss their implications. Careful consideration should be given to these during study design and when reporting findings from register-based studies on diagnosed mental disorders.',\n '2025 Plana-Ripoll et al.',\n 'DOI: 10.2147CLEP.S509147 PMCID: PMC12010038 PMID: 40260425',\n 'Conflict of interest statement: Dr Ole Khler-Forsberg reports personal fees from Lundbeck Pharma AS and WCG Clinical Services, outside the submitted work. Professor Henrik Toft Srensen reports funding for other studies in the form of institutional research grants to (and administered by) Aarhus University. None of these studies have any relation to the present study. The authors report no other conflicts of interest in this work.']"},"metadata":{}}],"execution_count":10},{"cell_type":"code","source":"def chunk_text(text, max_length=500):\n    sentences = sent_tokenize(text)\n    chunks, current_chunk = [], \"\"\n    for sent in sentences:\n        if len(current_chunk) + len(sent) <= max_length:\n            current_chunk += \" \" + sent\n        else:\n            chunks.append(current_chunk.strip())\n            current_chunk = sent\n    if current_chunk:\n        chunks.append(current_chunk.strip())\n    return chunks\n\ntext_chunks = []\nfor doc in cleaned_abstracts:\n    text_chunks.extend(chunk_text(doc))\n\nlen(text_chunks), text_chunks[:3]","metadata":{"trusted":true,"execution":{"iopub.status.busy":"2025-04-22T13:57:04.171774Z","iopub.execute_input":"2025-04-22T13:57:04.172106Z","iopub.status.idle":"2025-04-22T13:57:04.207186Z","shell.execute_reply.started":"2025-04-22T13:57:04.172074Z","shell.execute_reply":"2025-04-22T13:57:04.206059Z"}},"outputs":[{"execution_count":11,"output_type":"execute_result","data":{"text/plain":"(108,\n ['1. Subst Use Misuse. 2025 Apr 22:1-10. doi: 10.108010826084.2025.2495781. Online ahead of print.',\n  'The Impact of Timing of Alcohol Consumption on Implicit Drinking Identity Among College Students with Heavy Episodic Drinking: The Role of Social Anxiety.',\n  'Scherzer CR(1), Sullivan J(2), Buckner JD(1).'])"},"metadata":{}}],"execution_count":11},{"cell_type":"markdown","source":"# Phase 2: Embedding and FAISS Vector Store","metadata":{}},{"cell_type":"markdown","source":"\nNow that we have cleaned and chunked the text data, we convert each chunk into vector embeddings using a pre-trained model from `sentence-transformers`. Then, we store the vectors in **FAISS**, a high-performance similarity search library.\n","metadata":{}},{"cell_type":"code","source":"from sentence_transformers import SentenceTransformer\nimport numpy as np\nimport faiss\n\n# Load the lightweight biomedical transformer\nmodel = SentenceTransformer(\"sentence-transformers/all-MiniLM-L6-v2\")\n\n# Encode text chunks without progress bar (avoids widgets issue)\nembeddings = model.encode(text_chunks, show_progress_bar=False)  # Removed the progress bar\nembeddings = np.array(embeddings).astype(\"float32\")\n\n# Create FAISS index\nindex = faiss.IndexFlatL2(embeddings.shape[1])\nindex.add(embeddings)\n\n# Encode query\nquery_with_sentence = \"drugs for treating severe depression\"\nquery_vector = model.encode([query_with_sentence], show_progress_bar=False).astype(\"float32\")  # Also removed widget here\n\n# Perform similarity search\ntop_k = 5\ndistances, indices = index.search(query_vector, top_k)\n\n# Print results\nprint(\"🔎 Top retrieved chunks:\")\nfor idx in indices[0]:\n    print(\"-\", text_chunks[idx])\n","metadata":{"trusted":true,"execution":{"iopub.status.busy":"2025-04-22T13:57:04.208237Z","iopub.execute_input":"2025-04-22T13:57:04.208533Z","iopub.status.idle":"2025-04-22T13:57:09.244797Z","shell.execute_reply.started":"2025-04-22T13:57:04.208504Z","shell.execute_reply":"2025-04-22T13:57:09.243758Z"}},"outputs":[{"output_type":"display_data","data":{"text/plain":"modules.json:   0%|          | 0.00/349 [00:00<?, ?B/s]","application/vnd.jupyter.widget-view+json":{"version_major":2,"version_minor":0,"model_id":"a574a7608c3544c7bfaf91c1fb61f73b"}},"metadata":{}},{"output_type":"display_data","data":{"text/plain":"config_sentence_transformers.json:   0%|          | 0.00/116 [00:00<?, ?B/s]","application/vnd.jupyter.widget-view+json":{"version_major":2,"version_minor":0,"model_id":"cf480543e01c4ae5b4ba476891cb8d9b"}},"metadata":{}},{"output_type":"display_data","data":{"text/plain":"README.md:   0%|          | 0.00/10.5k [00:00<?, ?B/s]","application/vnd.jupyter.widget-view+json":{"version_major":2,"version_minor":0,"model_id":"77d4f6dbfa6841a9bf049074f39d76c6"}},"metadata":{}},{"output_type":"display_data","data":{"text/plain":"sentence_bert_config.json:   0%|          | 0.00/53.0 [00:00<?, ?B/s]","application/vnd.jupyter.widget-view+json":{"version_major":2,"version_minor":0,"model_id":"84322947d1884977a1333b95b4475050"}},"metadata":{}},{"output_type":"display_data","data":{"text/plain":"config.json:   0%|          | 0.00/612 [00:00<?, ?B/s]","application/vnd.jupyter.widget-view+json":{"version_major":2,"version_minor":0,"model_id":"d4f6bc752d2345978ebeb03cc25d7584"}},"metadata":{}},{"output_type":"display_data","data":{"text/plain":"model.safetensors:   0%|          | 0.00/90.9M [00:00<?, ?B/s]","application/vnd.jupyter.widget-view+json":{"version_major":2,"version_minor":0,"model_id":"b19face0cee743f58178acc60122016a"}},"metadata":{}},{"output_type":"display_data","data":{"text/plain":"tokenizer_config.json:   0%|          | 0.00/350 [00:00<?, ?B/s]","application/vnd.jupyter.widget-view+json":{"version_major":2,"version_minor":0,"model_id":"b2b1657d97bb4963a701c6da37781cb1"}},"metadata":{}},{"output_type":"display_data","data":{"text/plain":"vocab.txt:   0%|          | 0.00/232k [00:00<?, ?B/s]","application/vnd.jupyter.widget-view+json":{"version_major":2,"version_minor":0,"model_id":"8a328cb9ab694c2984c5e267fa0bc880"}},"metadata":{}},{"output_type":"display_data","data":{"text/plain":"tokenizer.json:   0%|          | 0.00/466k [00:00<?, ?B/s]","application/vnd.jupyter.widget-view+json":{"version_major":2,"version_minor":0,"model_id":"4113a591c3834b32b029f80ad3fe5c39"}},"metadata":{}},{"output_type":"display_data","data":{"text/plain":"special_tokens_map.json:   0%|          | 0.00/112 [00:00<?, ?B/s]","application/vnd.jupyter.widget-view+json":{"version_major":2,"version_minor":0,"model_id":"0a99a739066c4de8a056ede019d2e1f3"}},"metadata":{}},{"name":"stderr","text":"/opt/conda/lib/python3.10/site-packages/transformers/tokenization_utils_base.py:1617: FutureWarning: `clean_up_tokenization_spaces` was not set. It will be set to `True` by default. This behavior will be deprecated in transformers v4.45, and will be then set to `False` by default. For more details check this issue: https://github.com/huggingface/transformers/issues/31884\n  warnings.warn(\n","output_type":"stream"},{"output_type":"display_data","data":{"text/plain":"config.json:   0%|          | 0.00/190 [00:00<?, ?B/s]","application/vnd.jupyter.widget-view+json":{"version_major":2,"version_minor":0,"model_id":"15139e95d721481988951418b53bff88"}},"metadata":{}},{"name":"stdout","text":"🔎 Top retrieved chunks:\n- Therapeutic Targets and Molecular Mechanisms of Calycosin in the Treatment of Depression: Insights From Chronic Mild Stress Animal Models.\n- BACKGROUND: Depression is a complex psychiatric disorder with limited therapeutic options and various side effects. Calycosin, a bioactive compound derived from Astragalus membranaceus, possesses multiple pharmacological properties. This study aimed to investigate the antidepressant effects of calycosin in chronic mild stress (CMS) animal models of depression and to elucidate its underlying mechanisms.\n- METHODS: The antidepressant effects of calycosin were assessed in vivo using CMS animal models of depression, including the grooming frequency test, sucrose intake test, tail suspension test, and open field test. Neurogenic effects were evaluated by measuring the levels of BDNF, GDNF, and NGF in isolated hippocampus tissues. The hepatoprotective effects were assessed by measuring liver enzyme levels.\n- The molecular mechanisms underlying calycosins antidepressant effects were explored in vitro using PC12 cells. RESULTS: Calycosin exhibited potent antidepressant-like activities in CMS animal models of depression. Treatment with calycosin significantly alleviated depressive symptoms and improved neurogenic effects. Additionally, calycosin displayed hepatoprotective effects by modulating liver enzymes in vitro.\n- The antidepressant effects of calycosin are mediated by the stimulation of the TrkB-MEK-Erk12-CREB signaling pathway. CONCLUSION: In conclusion, calycosin shows promise as a novel therapeutic agent for depression due to its potent antidepressant-like activities and diverse pharmacological properties. Further studies are warranted to elucidate the exact molecular targets of calycosin and to assess its efficacy and safety in clinical settings.\n","output_type":"stream"}],"execution_count":12},{"cell_type":"markdown","source":"#### Index the Embeddings Using FAISS","metadata":{}},{"cell_type":"code","source":"# Create FAISS index\ndimension = embeddings.shape[1]\nindex = faiss.IndexFlatL2(dimension)\nindex.add(embeddings)\nindex.ntotal","metadata":{"trusted":true,"execution":{"iopub.status.busy":"2025-04-22T13:57:09.246285Z","iopub.execute_input":"2025-04-22T13:57:09.246737Z","iopub.status.idle":"2025-04-22T13:57:09.254351Z","shell.execute_reply.started":"2025-04-22T13:57:09.246663Z","shell.execute_reply":"2025-04-22T13:57:09.253341Z"}},"outputs":[{"execution_count":13,"output_type":"execute_result","data":{"text/plain":"108"},"metadata":{}}],"execution_count":13},{"cell_type":"markdown","source":"#### Sample Similarity Search","metadata":{}},{"cell_type":"code","source":"\n# Query with a new sentence\nquery = \"drugs for treating severe depression\"\nquery_vector = model.encode([query]).astype(\"float32\")\n\n# Search\ntop_k = 5\ndistances, indices = index.search(query_vector, top_k)\n\nprint(\"🔎 Top retrieved chunks:\")\nfor idx in indices[0]:\n    print(\"-\", text_chunks[idx])\n    ","metadata":{"trusted":true,"execution":{"iopub.status.busy":"2025-04-22T13:57:09.255600Z","iopub.execute_input":"2025-04-22T13:57:09.255946Z","iopub.status.idle":"2025-04-22T13:57:09.306683Z","shell.execute_reply.started":"2025-04-22T13:57:09.255916Z","shell.execute_reply":"2025-04-22T13:57:09.305715Z"}},"outputs":[{"output_type":"display_data","data":{"text/plain":"Batches:   0%|          | 0/1 [00:00<?, ?it/s]","application/vnd.jupyter.widget-view+json":{"version_major":2,"version_minor":0,"model_id":"dbdbd88b72a248fab37e1088710ab2e5"}},"metadata":{}},{"name":"stdout","text":"🔎 Top retrieved chunks:\n- Therapeutic Targets and Molecular Mechanisms of Calycosin in the Treatment of Depression: Insights From Chronic Mild Stress Animal Models.\n- BACKGROUND: Depression is a complex psychiatric disorder with limited therapeutic options and various side effects. Calycosin, a bioactive compound derived from Astragalus membranaceus, possesses multiple pharmacological properties. This study aimed to investigate the antidepressant effects of calycosin in chronic mild stress (CMS) animal models of depression and to elucidate its underlying mechanisms.\n- METHODS: The antidepressant effects of calycosin were assessed in vivo using CMS animal models of depression, including the grooming frequency test, sucrose intake test, tail suspension test, and open field test. Neurogenic effects were evaluated by measuring the levels of BDNF, GDNF, and NGF in isolated hippocampus tissues. The hepatoprotective effects were assessed by measuring liver enzyme levels.\n- The molecular mechanisms underlying calycosins antidepressant effects were explored in vitro using PC12 cells. RESULTS: Calycosin exhibited potent antidepressant-like activities in CMS animal models of depression. Treatment with calycosin significantly alleviated depressive symptoms and improved neurogenic effects. Additionally, calycosin displayed hepatoprotective effects by modulating liver enzymes in vitro.\n- The antidepressant effects of calycosin are mediated by the stimulation of the TrkB-MEK-Erk12-CREB signaling pathway. CONCLUSION: In conclusion, calycosin shows promise as a novel therapeutic agent for depression due to its potent antidepressant-like activities and diverse pharmacological properties. Further studies are warranted to elucidate the exact molecular targets of calycosin and to assess its efficacy and safety in clinical settings.\n","output_type":"stream"}],"execution_count":14},{"cell_type":"code","source":"\n# Query with a new sentence\nquery = \"drugs for treating severe anxiety\"\nquery_vector = model.encode([query]).astype(\"float32\")\n\n# Search\ntop_k = 5\ndistances, indices = index.search(query_vector, top_k)\n\nprint(\"🔎 Top retrieved chunks:\")\nfor idx in indices[0]:\n    print(\"-\", text_chunks[idx])\n    ","metadata":{"trusted":true,"execution":{"iopub.status.busy":"2025-04-22T13:57:09.310365Z","iopub.execute_input":"2025-04-22T13:57:09.310717Z","iopub.status.idle":"2025-04-22T13:57:09.347567Z","shell.execute_reply.started":"2025-04-22T13:57:09.310657Z","shell.execute_reply":"2025-04-22T13:57:09.346496Z"}},"outputs":[{"output_type":"display_data","data":{"text/plain":"Batches:   0%|          | 0/1 [00:00<?, ?it/s]","application/vnd.jupyter.widget-view+json":{"version_major":2,"version_minor":0,"model_id":"30313225e3204547a56557975d34dc3e"}},"metadata":{}},{"name":"stdout","text":"🔎 Top retrieved chunks:\n- Author information: (1)Department of Psychiatry Behavioral Sciences, Memorial Sloan Kettering Cancer Center, New York, NY, USA.\n- BACKGROUND: Depression is a complex psychiatric disorder with limited therapeutic options and various side effects. Calycosin, a bioactive compound derived from Astragalus membranaceus, possesses multiple pharmacological properties. This study aimed to investigate the antidepressant effects of calycosin in chronic mild stress (CMS) animal models of depression and to elucidate its underlying mechanisms.\n- Therapeutic Targets and Molecular Mechanisms of Calycosin in the Treatment of Depression: Insights From Chronic Mild Stress Animal Models.\n- METHODS: The antidepressant effects of calycosin were assessed in vivo using CMS animal models of depression, including the grooming frequency test, sucrose intake test, tail suspension test, and open field test. Neurogenic effects were evaluated by measuring the levels of BDNF, GDNF, and NGF in isolated hippocampus tissues. The hepatoprotective effects were assessed by measuring liver enzyme levels.\n- Retrospective surveys assessed anxiety reduction, social connection, and physical well-being using Likert scales and participants provided open-ended responses. Quantitative data were analyzed with ordinal regression and probability modeling, while qualitative themes were explored with Fishers exact test.ResultsParticipants reported high levels of satisfaction across all measures. Sing-along programs provided greater satisfaction, particularly through reminiscence (p 0.003).\n","output_type":"stream"}],"execution_count":15},{"cell_type":"code","source":"\n# Query with a new sentence\nquery = \"drugs for treating severe psychosis\"\nquery_vector = model.encode([query]).astype(\"float32\")\n\n# Search\ntop_k = 5\ndistances, indices = index.search(query_vector, top_k)\n\nprint(\"🔎 Top retrieved chunks:\")\nfor idx in indices[0]:\n    print(\"-\", text_chunks[idx])\n    ","metadata":{"trusted":true,"execution":{"iopub.status.busy":"2025-04-22T13:57:09.348761Z","iopub.execute_input":"2025-04-22T13:57:09.349048Z","iopub.status.idle":"2025-04-22T13:57:09.388414Z","shell.execute_reply.started":"2025-04-22T13:57:09.349020Z","shell.execute_reply":"2025-04-22T13:57:09.387315Z"}},"outputs":[{"output_type":"display_data","data":{"text/plain":"Batches:   0%|          | 0/1 [00:00<?, ?it/s]","application/vnd.jupyter.widget-view+json":{"version_major":2,"version_minor":0,"model_id":"e525981b04b44b7caf7c3a000b6eb955"}},"metadata":{}},{"name":"stdout","text":"🔎 Top retrieved chunks:\n- Author information: (1)Department of Clinical Epidemiology, Center for Population Medicine, Aarhus University and Aarhus University Hospital, Aarhus, Denmark. (2)National Centre for Register-based Research, Department of Public Health, Aarhus University, Aarhus, Denmark. (3)Department of Clinical Medicine, Aarhus University, Aarhus, Denmark. (4)Psychosis Research Unit, Aarhus University Hospital Psychiatry, Aarhus, Denmark.\n- Author information: (1)Department of Psychiatry Behavioral Sciences, Memorial Sloan Kettering Cancer Center, New York, NY, USA.\n- Therapeutic Targets and Molecular Mechanisms of Calycosin in the Treatment of Depression: Insights From Chronic Mild Stress Animal Models.\n- Author information: (1)Seccin de Medicina Paliativa, Facultad de Medicina, Pontificia Universidad Catlica de Chile, Santiago, Chile. (2)Centro para el Control y la Prevencin del Cncer (CECAN), Pontificia Universidad Catlica de Chile, Santiago, Chile. (3)Escuela de Psicologa, Facultad de Educacin, Psicologa y Familia, Universidad Finis Terrae, Santiago, Chile. (4)Programa de Medicina Paliativa y Cuidados Continuos, Facultad de Medicina, Pontificia Universidad Catlica de Chile, Santiago, Chile.\n- BACKGROUND: Depression is a complex psychiatric disorder with limited therapeutic options and various side effects. Calycosin, a bioactive compound derived from Astragalus membranaceus, possesses multiple pharmacological properties. This study aimed to investigate the antidepressant effects of calycosin in chronic mild stress (CMS) animal models of depression and to elucidate its underlying mechanisms.\n","output_type":"stream"}],"execution_count":16},{"cell_type":"code","source":"\n# Step 1: Query the vector store with the sentence\nquery = \"drugs for treating severe depression\"\nquery_vector = model.encode([query]).astype(\"float32\")\n\n# Step 2: Search FAISS index\ntop_k = 5\ndistances, indices = index.search(query_vector, top_k)\n\n# Step 3: Organize and display results\nretrieved_data = []\n\nfor rank, idx in enumerate(indices[0]):\n    chunk_text = text_chunks[idx]\n    score = distances[0][rank]\n    retrieved_data.append({\"Rank\": rank + 1, \"Similarity Score\": f\"{score:.4f}\", \"Retrieved Chunk\": chunk_text})\n\n# Convert to DataFrame\nretrieved_df = pd.DataFrame(retrieved_data)\n\n# Display results\nprint(\"🔍 Top Retrieved Chunks for Query:\")\nretrieved_df\n\n    ","metadata":{"trusted":true,"execution":{"iopub.status.busy":"2025-04-22T13:57:09.389684Z","iopub.execute_input":"2025-04-22T13:57:09.390014Z","iopub.status.idle":"2025-04-22T13:57:09.443330Z","shell.execute_reply.started":"2025-04-22T13:57:09.389981Z","shell.execute_reply":"2025-04-22T13:57:09.442122Z"}},"outputs":[{"output_type":"display_data","data":{"text/plain":"Batches:   0%|          | 0/1 [00:00<?, ?it/s]","application/vnd.jupyter.widget-view+json":{"version_major":2,"version_minor":0,"model_id":"dc282aaf4f874453919cbc9a1138b6a5"}},"metadata":{}},{"name":"stdout","text":"🔍 Top Retrieved Chunks for Query:\n","output_type":"stream"},{"execution_count":17,"output_type":"execute_result","data":{"text/plain":"   Rank Similarity Score                                    Retrieved Chunk\n0     1           0.9440  Therapeutic Targets and Molecular Mechanisms o...\n1     2           1.0071  BACKGROUND: Depression is a complex psychiatri...\n2     3           1.0203  METHODS: The antidepressant effects of calycos...\n3     4           1.0287  The molecular mechanisms underlying calycosins...\n4     5           1.0848  The antidepressant effects of calycosin are me...","text/html":"<div>\n<style scoped>\n    .dataframe tbody tr th:only-of-type {\n        vertical-align: middle;\n    }\n\n    .dataframe tbody tr th {\n        vertical-align: top;\n    }\n\n    .dataframe thead th {\n        text-align: right;\n    }\n</style>\n<table border=\"1\" class=\"dataframe\">\n  <thead>\n    <tr style=\"text-align: right;\">\n      <th></th>\n      <th>Rank</th>\n      <th>Similarity Score</th>\n      <th>Retrieved Chunk</th>\n    </tr>\n  </thead>\n  <tbody>\n    <tr>\n      <th>0</th>\n      <td>1</td>\n      <td>0.9440</td>\n      <td>Therapeutic Targets and Molecular Mechanisms o...</td>\n    </tr>\n    <tr>\n      <th>1</th>\n      <td>2</td>\n      <td>1.0071</td>\n      <td>BACKGROUND: Depression is a complex psychiatri...</td>\n    </tr>\n    <tr>\n      <th>2</th>\n      <td>3</td>\n      <td>1.0203</td>\n      <td>METHODS: The antidepressant effects of calycos...</td>\n    </tr>\n    <tr>\n      <th>3</th>\n      <td>4</td>\n      <td>1.0287</td>\n      <td>The molecular mechanisms underlying calycosins...</td>\n    </tr>\n    <tr>\n      <th>4</th>\n      <td>5</td>\n      <td>1.0848</td>\n      <td>The antidepressant effects of calycosin are me...</td>\n    </tr>\n  </tbody>\n</table>\n</div>"},"metadata":{}}],"execution_count":17},{"cell_type":"code","source":"# Query the vector store for anxiety\nquery_anxiety = \"drugs for treating anxiety disorders\"\nquery_vector_anxiety = model.encode([query_anxiety]).astype(\"float32\")\n\n# Search\ndistances_anxiety, indices_anxiety = index.search(query_vector_anxiety, top_k)\n\n# Process and display\nretrieved_data_anxiety = []\n\nfor rank, idx in enumerate(indices_anxiety[0]):\n    chunk_text = text_chunks[idx]\n    score = distances_anxiety[0][rank]\n    retrieved_data_anxiety.append({\n        \"Rank\": rank + 1,\n        \"Similarity Score\": f\"{score:.4f}\",\n        \"Retrieved Chunk\": chunk_text\n    })\n\nretrieved_df_anxiety = pd.DataFrame(retrieved_data_anxiety)\n\nprint(\"🔍 Top Retrieved Chunks for Anxiety Query:\")\nretrieved_df_anxiety\n","metadata":{"trusted":true,"execution":{"iopub.status.busy":"2025-04-22T13:57:09.444531Z","iopub.execute_input":"2025-04-22T13:57:09.445360Z","iopub.status.idle":"2025-04-22T13:57:09.496497Z","shell.execute_reply.started":"2025-04-22T13:57:09.445317Z","shell.execute_reply":"2025-04-22T13:57:09.495558Z"}},"outputs":[{"output_type":"display_data","data":{"text/plain":"Batches:   0%|          | 0/1 [00:00<?, ?it/s]","application/vnd.jupyter.widget-view+json":{"version_major":2,"version_minor":0,"model_id":"152fdea72fc94da388a5a45fca1a8388"}},"metadata":{}},{"name":"stdout","text":"🔍 Top Retrieved Chunks for Anxiety Query:\n","output_type":"stream"},{"execution_count":18,"output_type":"execute_result","data":{"text/plain":"   Rank Similarity Score                                    Retrieved Chunk\n0     1           1.2516  Author information: (1)Department of Psychiatr...\n1     2           1.2861  2025 The Author(s). CNS Neuroscience Therapeut...\n2     3           1.2922  Retrospective surveys assessed anxiety reducti...\n3     4           1.3048  BACKGROUND: Depression is a complex psychiatri...\n4     5           1.3121  METHODS: The antidepressant effects of calycos...","text/html":"<div>\n<style scoped>\n    .dataframe tbody tr th:only-of-type {\n        vertical-align: middle;\n    }\n\n    .dataframe tbody tr th {\n        vertical-align: top;\n    }\n\n    .dataframe thead th {\n        text-align: right;\n    }\n</style>\n<table border=\"1\" class=\"dataframe\">\n  <thead>\n    <tr style=\"text-align: right;\">\n      <th></th>\n      <th>Rank</th>\n      <th>Similarity Score</th>\n      <th>Retrieved Chunk</th>\n    </tr>\n  </thead>\n  <tbody>\n    <tr>\n      <th>0</th>\n      <td>1</td>\n      <td>1.2516</td>\n      <td>Author information: (1)Department of Psychiatr...</td>\n    </tr>\n    <tr>\n      <th>1</th>\n      <td>2</td>\n      <td>1.2861</td>\n      <td>2025 The Author(s). CNS Neuroscience Therapeut...</td>\n    </tr>\n    <tr>\n      <th>2</th>\n      <td>3</td>\n      <td>1.2922</td>\n      <td>Retrospective surveys assessed anxiety reducti...</td>\n    </tr>\n    <tr>\n      <th>3</th>\n      <td>4</td>\n      <td>1.3048</td>\n      <td>BACKGROUND: Depression is a complex psychiatri...</td>\n    </tr>\n    <tr>\n      <th>4</th>\n      <td>5</td>\n      <td>1.3121</td>\n      <td>METHODS: The antidepressant effects of calycos...</td>\n    </tr>\n  </tbody>\n</table>\n</div>"},"metadata":{}}],"execution_count":18},{"cell_type":"code","source":"# Query the vector store for psychosis\nquery_psychosis = \"drug treatments for psychosis and schizophrenia\"\nquery_vector_psychosis = model.encode([query_psychosis]).astype(\"float32\")\n\n# Search\ndistances_psychosis, indices_psychosis = index.search(query_vector_psychosis, top_k)\n\n# Process and display\nretrieved_data_psychosis = []\n\nfor rank, idx in enumerate(indices_psychosis[0]):\n    chunk_text = text_chunks[idx]\n    score = distances_psychosis[0][rank]\n    retrieved_data_psychosis.append({\n        \"Rank\": rank + 1,\n        \"Similarity Score\": f\"{score:.4f}\",\n        \"Retrieved Chunk\": chunk_text\n    })\n\nretrieved_df_psychosis = pd.DataFrame(retrieved_data_psychosis)\n\nprint(\"🔍 Top Retrieved Chunks for Psychosis Query:\")\nretrieved_df_psychosis\n","metadata":{"trusted":true,"execution":{"iopub.status.busy":"2025-04-22T13:57:09.497720Z","iopub.execute_input":"2025-04-22T13:57:09.498041Z","iopub.status.idle":"2025-04-22T13:57:09.546703Z","shell.execute_reply.started":"2025-04-22T13:57:09.498005Z","shell.execute_reply":"2025-04-22T13:57:09.545721Z"}},"outputs":[{"output_type":"display_data","data":{"text/plain":"Batches:   0%|          | 0/1 [00:00<?, ?it/s]","application/vnd.jupyter.widget-view+json":{"version_major":2,"version_minor":0,"model_id":"2e32b97d931f4ad1bffdd6ef7437ef05"}},"metadata":{}},{"name":"stdout","text":"🔍 Top Retrieved Chunks for Psychosis Query:\n","output_type":"stream"},{"execution_count":19,"output_type":"execute_result","data":{"text/plain":"   Rank Similarity Score                                    Retrieved Chunk\n0     1           1.0543  Author information: (1)Department of Clinical ...\n1     2           1.2292  Author information: (1)Department of Psychiatr...\n2     3           1.2945  Author information: (1)Seccin de Medicina Pali...\n3     4           1.3284  2025 The Author(s). CNS Neuroscience Therapeut...\n4     5           1.3478  9. Span J Psychol. 2025 Apr 22;28:e11. doi: 10...","text/html":"<div>\n<style scoped>\n    .dataframe tbody tr th:only-of-type {\n        vertical-align: middle;\n    }\n\n    .dataframe tbody tr th {\n        vertical-align: top;\n    }\n\n    .dataframe thead th {\n        text-align: right;\n    }\n</style>\n<table border=\"1\" class=\"dataframe\">\n  <thead>\n    <tr style=\"text-align: right;\">\n      <th></th>\n      <th>Rank</th>\n      <th>Similarity Score</th>\n      <th>Retrieved Chunk</th>\n    </tr>\n  </thead>\n  <tbody>\n    <tr>\n      <th>0</th>\n      <td>1</td>\n      <td>1.0543</td>\n      <td>Author information: (1)Department of Clinical ...</td>\n    </tr>\n    <tr>\n      <th>1</th>\n      <td>2</td>\n      <td>1.2292</td>\n      <td>Author information: (1)Department of Psychiatr...</td>\n    </tr>\n    <tr>\n      <th>2</th>\n      <td>3</td>\n      <td>1.2945</td>\n      <td>Author information: (1)Seccin de Medicina Pali...</td>\n    </tr>\n    <tr>\n      <th>3</th>\n      <td>4</td>\n      <td>1.3284</td>\n      <td>2025 The Author(s). CNS Neuroscience Therapeut...</td>\n    </tr>\n    <tr>\n      <th>4</th>\n      <td>5</td>\n      <td>1.3478</td>\n      <td>9. Span J Psychol. 2025 Apr 22;28:e11. doi: 10...</td>\n    </tr>\n  </tbody>\n</table>\n</div>"},"metadata":{}}],"execution_count":19},{"cell_type":"code","source":"# Query the vector store for depression\nquery_depression = \"drugs for treating severe depression\"\nquery_vector_depression = model.encode([query_depression]).astype(\"float32\")\n\n# Search\ntop_k = 5\ndistances_depression, indices_depression = index.search(query_vector_depression, top_k)\n\n# Process and display\nretrieved_data_depression = []\n\nfor rank, idx in enumerate(indices_depression[0]):\n    chunk_text = text_chunks[idx]\n    score = distances_depression[0][rank]\n    retrieved_data_depression.append({\n        \"Rank\": rank + 1,\n        \"Similarity Score\": f\"{score:.4f}\",\n        \"Retrieved Chunk\": chunk_text\n    })\n\nretrieved_df_depression = pd.DataFrame(retrieved_data_depression)\n\nprint(\"🔍 Top Retrieved Chunks for Depression Query:\")\nretrieved_df_depression\n","metadata":{"trusted":true,"execution":{"iopub.status.busy":"2025-04-22T13:57:09.548064Z","iopub.execute_input":"2025-04-22T13:57:09.548381Z","iopub.status.idle":"2025-04-22T13:57:09.598661Z","shell.execute_reply.started":"2025-04-22T13:57:09.548351Z","shell.execute_reply":"2025-04-22T13:57:09.597724Z"}},"outputs":[{"output_type":"display_data","data":{"text/plain":"Batches:   0%|          | 0/1 [00:00<?, ?it/s]","application/vnd.jupyter.widget-view+json":{"version_major":2,"version_minor":0,"model_id":"6b397616ba3b423ba4481219402c963f"}},"metadata":{}},{"name":"stdout","text":"🔍 Top Retrieved Chunks for Depression Query:\n","output_type":"stream"},{"execution_count":20,"output_type":"execute_result","data":{"text/plain":"   Rank Similarity Score                                    Retrieved Chunk\n0     1           0.9440  Therapeutic Targets and Molecular Mechanisms o...\n1     2           1.0071  BACKGROUND: Depression is a complex psychiatri...\n2     3           1.0203  METHODS: The antidepressant effects of calycos...\n3     4           1.0287  The molecular mechanisms underlying calycosins...\n4     5           1.0848  The antidepressant effects of calycosin are me...","text/html":"<div>\n<style scoped>\n    .dataframe tbody tr th:only-of-type {\n        vertical-align: middle;\n    }\n\n    .dataframe tbody tr th {\n        vertical-align: top;\n    }\n\n    .dataframe thead th {\n        text-align: right;\n    }\n</style>\n<table border=\"1\" class=\"dataframe\">\n  <thead>\n    <tr style=\"text-align: right;\">\n      <th></th>\n      <th>Rank</th>\n      <th>Similarity Score</th>\n      <th>Retrieved Chunk</th>\n    </tr>\n  </thead>\n  <tbody>\n    <tr>\n      <th>0</th>\n      <td>1</td>\n      <td>0.9440</td>\n      <td>Therapeutic Targets and Molecular Mechanisms o...</td>\n    </tr>\n    <tr>\n      <th>1</th>\n      <td>2</td>\n      <td>1.0071</td>\n      <td>BACKGROUND: Depression is a complex psychiatri...</td>\n    </tr>\n    <tr>\n      <th>2</th>\n      <td>3</td>\n      <td>1.0203</td>\n      <td>METHODS: The antidepressant effects of calycos...</td>\n    </tr>\n    <tr>\n      <th>3</th>\n      <td>4</td>\n      <td>1.0287</td>\n      <td>The molecular mechanisms underlying calycosins...</td>\n    </tr>\n    <tr>\n      <th>4</th>\n      <td>5</td>\n      <td>1.0848</td>\n      <td>The antidepressant effects of calycosin are me...</td>\n    </tr>\n  </tbody>\n</table>\n</div>"},"metadata":{}}],"execution_count":20},{"cell_type":"markdown","source":"### Define Retrieval + Gemini 2.0 RAG Pipeline","metadata":{}},{"cell_type":"code","source":"def retrieve_relevant_chunks(query, top_k=5):\n    query_vector = model.encode([query]).astype(\"float32\")\n    distances, indices = index.search(query_vector, top_k)\n    return [text_chunks[i] for i in indices[0]]\n\ndef generate_rag_response(query):\n    # Configure the API key (ensure this is set before calling)\n    genai.configure(api_key=secret_value)  \n\n    # Initialize the Gemini model\n    model = genai.GenerativeModel(\"gemini-2.0-flash\")  # Adjust model name based on availability\n\n    # Create the prompt (modify as needed for your RAG setup)\n    prompt = f\"Answer the following query based on the latest available information: {query}\"\n\n    # Generate content using the model\n    response = model.generate_content(prompt)\n    return response.text","metadata":{"trusted":true,"execution":{"iopub.status.busy":"2025-04-22T13:57:09.600007Z","iopub.execute_input":"2025-04-22T13:57:09.600339Z","iopub.status.idle":"2025-04-22T13:57:09.607056Z","shell.execute_reply.started":"2025-04-22T13:57:09.600307Z","shell.execute_reply":"2025-04-22T13:57:09.605915Z"}},"outputs":[],"execution_count":21},{"cell_type":"markdown","source":"### Test: Drug Targets for Depression","metadata":{}},{"cell_type":"code","source":"# Run the query\nquery = \"What are the latest drug targets for treating depression?\"\nresponse = generate_rag_response(query)\nprint(\"🤖 Gemini 2.0 Response:\\n\")\nprint(response)","metadata":{"trusted":true,"execution":{"iopub.status.busy":"2025-04-22T13:57:09.608490Z","iopub.execute_input":"2025-04-22T13:57:09.609306Z","iopub.status.idle":"2025-04-22T13:57:18.929784Z","shell.execute_reply.started":"2025-04-22T13:57:09.609258Z","shell.execute_reply":"2025-04-22T13:57:18.928740Z"}},"outputs":[{"name":"stdout","text":"🤖 Gemini 2.0 Response:\n\nWhile research into new drug targets for depression is constantly evolving, here's a summary of the latest information, categorized for clarity:\n\n**1. Targets Beyond the Monoamines (Serotonin, Norepinephrine, Dopamine):**\n\n*   **Glutamate System:**\n    *   **NMDA Receptor Modulation:**\n        *   **Ketamine and Esketamine:**  Esketamine (Spravato), a nasal spray, is an NMDA receptor antagonist approved for treatment-resistant depression (TRD). It's known for its rapid antidepressant effects.  Research is ongoing to understand the precise mechanisms and optimize its use, including exploring different administration routes and maintenance strategies.\n        *   **Other NMDA Receptor Modulators:**  Researchers are developing and testing other NMDA receptor modulators with different binding sites or mechanisms of action, aiming for improved efficacy, safety, and tolerability compared to ketamine.  Examples include partial agonists, glycine site modulators, and antagonists with different pharmacokinetic properties.\n    *   **AMPA Receptor Modulation:**  Enhancing AMPA receptor activity is another area of focus, as it can increase synaptic plasticity and glutamate signaling.  AMPA receptor potentiators are being investigated.\n    *   **Metabotropic Glutamate Receptors (mGluRs):**  Various mGluR subtypes (e.g., mGluR2/3, mGluR5) are being explored as potential targets.  Modulators of these receptors might offer antidepressant effects with fewer side effects than traditional antidepressants.\n\n*   **Neurotrophic Factors and Synaptic Plasticity:**\n    *   **Brain-Derived Neurotrophic Factor (BDNF):**  BDNF plays a critical role in neuronal survival, growth, and synaptic plasticity.  Strategies to increase BDNF levels or enhance its signaling pathways are being investigated.  This includes:\n        *   **TrkB Receptor Agonists:**  Developing drugs that directly activate the TrkB receptor (the receptor for BDNF).\n        *   **Indirect BDNF Modulators:**  Finding ways to increase BDNF expression through other mechanisms, such as epigenetic modifications or activation of other signaling pathways.\n\n*   **Inflammation and the Immune System:**\n    *   **Cytokine Modulation:**  Chronic inflammation is increasingly recognized as a contributing factor to depression in some individuals.  Targeting specific cytokines (e.g., TNF-alpha, IL-6) with anti-inflammatory agents or immunomodulatory drugs is being explored.  This is particularly relevant for depression associated with chronic medical conditions.\n    *   **Microglia Modulation:**  Microglia, the brain's resident immune cells, can become overactive in depression.  Modulating microglia activity to reduce neuroinflammation is a potential therapeutic strategy.\n\n*   **GABA System:**\n    *   **GABA-A Receptor Subtype Specificity:**  Developing drugs that selectively target specific GABA-A receptor subtypes to achieve more targeted effects and reduce side effects associated with broad GABA-A receptor modulation.\n    *   **Allosteric Modulators:** Focusing on novel allosteric modulators of GABA-A receptors that might offer improved efficacy or tolerability.\n\n*   **Opioid System:**\n     *  **Kappa Opioid Receptor (KOR) Antagonists:** KOR activation can contribute to dysphoria and anhedonia, key symptoms of depression. KOR antagonists are under investigation as potential antidepressants.\n\n*   **Circadian Rhythm and Sleep:**\n    *   **Melatonin Receptor Agonists:**  Melatonin receptor agonists (like melatonin itself and ramelteon) can help regulate sleep-wake cycles and may have antidepressant effects, particularly in individuals with circadian rhythm disturbances.\n    *   **Other Circadian Rhythm Modulators:**  Exploring other ways to stabilize circadian rhythms, such as light therapy or chronotherapy, in combination with pharmacological interventions.\n\n*   **Hormonal Influences:**\n    *   **CRF (Corticotropin-Releasing Factor) Receptor Antagonists:**  CRF plays a key role in the stress response. Blocking CRF receptors may reduce anxiety and depression symptoms related to chronic stress.\n    *   **Steroid Hormone Modulation:**  Investigating the role of hormones like estrogen, progesterone, and testosterone in depression, particularly in specific populations (e.g., postpartum depression, perimenopausal depression).\n\n*   **Epigenetics:**\n    *   Targeting enzymes involved in DNA methylation and histone modification to alter gene expression patterns relevant to depression.  This is a very early-stage area of research.\n\n**2.  Refining Monoamine-Based Treatments:**\n\n*   **Multi-Targeting Drugs:**  Developing drugs that act on multiple monoamine receptors or combine monoamine modulation with effects on other systems (e.g., glutamate).  Vortioxetine is an example, combining serotonin reuptake inhibition with effects on serotonin receptors.\n*   **Personalized Medicine:**  Using genetic or other biomarkers to predict which patients are most likely to respond to specific antidepressants or to experience side effects.\n\n**Important Considerations:**\n\n*   **Clinical Trials:**  Many of these potential targets are still in early stages of development and require rigorous clinical trials to determine their efficacy and safety.\n*   **Heterogeneity of Depression:**  Depression is a complex and heterogeneous disorder, and different individuals may respond to different treatments.  Personalized medicine approaches are crucial.\n*   **Combination Therapies:**  Combining pharmacological treatments with psychotherapy and lifestyle interventions (e.g., exercise, diet) is often the most effective approach to managing depression.\n\n**How to Stay Updated:**\n\n*   **Reputable Medical Journals:**  Follow publications like *The American Journal of Psychiatry*, *JAMA Psychiatry*, *Biological Psychiatry*, and *Molecular Psychiatry*.\n*   **Professional Organizations:**  Keep up with news and research from organizations like the American Psychiatric Association (APA) and the National Institute of Mental Health (NIMH).\n*   **Medical News Websites:**  Read articles from reliable medical news sources, but be critical and cautious about sensationalized claims.\n\nThis information is for general knowledge and informational purposes only, and does not constitute medical advice. It is essential to consult with a qualified healthcare professional for any health concerns or before making any decisions related to your health or treatment.\n\n","output_type":"stream"}],"execution_count":22},{"cell_type":"code","source":"query1 = \"What are the latest drug targets for treating anxiety?\"\nresponse = generate_rag_response(query1)\nprint(\"🤖 Gemini 2.0 Response:\\n\")\nprint(response)","metadata":{"trusted":true,"execution":{"iopub.status.busy":"2025-04-22T13:57:18.931213Z","iopub.execute_input":"2025-04-22T13:57:18.931627Z","iopub.status.idle":"2025-04-22T13:57:27.850346Z","shell.execute_reply.started":"2025-04-22T13:57:18.931582Z","shell.execute_reply":"2025-04-22T13:57:27.849262Z"}},"outputs":[{"name":"stdout","text":"🤖 Gemini 2.0 Response:\n\nOkay, let's break down the latest research and potential drug targets for treating anxiety. It's important to remember that drug development is a long process, and many of these targets are still in preclinical or clinical trials. Also, the \"best\" target often depends on the specific type of anxiety disorder (e.g., generalized anxiety disorder, social anxiety disorder, panic disorder).\n\n**Established Targets with Ongoing Research & Refinement:**\n\n*   **Serotonin (5-HT) System:**\n    *   *SSRIs (Selective Serotonin Reuptake Inhibitors):*  Still a mainstay. Research focuses on optimizing dosing, managing side effects, and understanding individual variability in response.  Pharmacogenomics (studying how genes affect a person's response to drugs) is playing an increasingly important role here.\n    *   *Serotonin Receptors (5-HT1A, 5-HT2A, etc.):*  Beyond simply increasing serotonin levels, researchers are exploring more selective agonists (activators) or antagonists (blockers) for specific serotonin receptor subtypes to achieve better efficacy and fewer side effects.  For example, buspirone is a partial 5-HT1A agonist used for anxiety.\n    *   *Serotonin Transporter (SERT) Modulation:*  Research continues on how to best modulate SERT activity, including exploring novel compounds that might have faster onset of action or different side effect profiles than traditional SSRIs.\n\n*   **GABA (Gamma-Aminobutyric Acid) System:**\n    *   *Benzodiazepines:*  While effective for short-term relief, their use is limited by tolerance, dependence, and withdrawal symptoms.  Research is focused on developing safer GABAergic medications.\n    *   *GABA-A Receptor Subtypes:*  The GABA-A receptor has various subunits, and drugs that selectively target specific subunit combinations are being investigated.  The goal is to achieve anxiolytic effects without the sedative or cognitive side effects associated with non-selective benzodiazepines. Some examples of these are drugs that selectively target the alpha2/3 subunits of the GABAA receptor.\n\n**Emerging and Promising Drug Targets:**\n\n*   **Glutamate System:**\n    *   *NMDA Receptor Antagonists:*  Ketamine (and its derivative esketamine) have shown rapid antidepressant and potentially anxiolytic effects, likely through NMDA receptor antagonism. However, concerns about abuse potential and side effects exist. Research focuses on developing safer and more targeted NMDA receptor modulators.\n    *   *AMPA Receptor Modulators:*  AMPA receptors are another type of glutamate receptor. Modulating their activity could offer anxiolytic benefits.\n    *   *Metabotropic Glutamate Receptors (mGluRs):*  Specific mGluR subtypes (e.g., mGluR5) are being investigated as potential targets.  Modulating these receptors could help regulate glutamate transmission and reduce anxiety.\n\n*   **Neuropeptides:**\n    *   *Corticotropin-Releasing Factor (CRF) Receptors (CRF1, CRF2):*  CRF plays a key role in the stress response.  CRF1 receptor antagonists have shown promise in preclinical studies, but clinical trial results have been mixed. Research is ongoing to identify more effective CRF receptor modulators.\n    *   *Neuropeptide Y (NPY) Receptors:*  NPY is involved in regulating anxiety and stress. NPY receptor agonists are being explored as potential anxiolytics.\n    *   *Tachykinin NK1 Receptor:*  NK1 receptors are involved in the stress response. Selective NK1 receptor antagonists are being investigated.\n    *   *Orexin Receptors:* Also known as hypocretin receptors, orexin is a neuropeptide involved in wakefulness and arousal. Blocking these receptors has shown promise in anxiety treatment.\n\n*   **Neuroinflammation:**\n    *   *Cytokine Modulation:*  Evidence suggests that neuroinflammation plays a role in anxiety disorders.  Targeting inflammatory cytokines (e.g., TNF-alpha, IL-1beta, IL-6) could potentially reduce anxiety.\n    *   *Microglia Modulation:*  Microglia are immune cells in the brain.  Modulating their activity could reduce neuroinflammation and improve anxiety symptoms.\n\n*   **The Gut-Brain Axis:**\n    *   *Probiotics/Prebiotics:*  Research suggests a link between gut microbiota and anxiety.  Modulating the gut microbiome with probiotics or prebiotics could potentially improve anxiety symptoms.\n    *   *Vagus Nerve Stimulation (VNS):*  The vagus nerve connects the gut to the brain.  Stimulating the vagus nerve could influence brain activity and reduce anxiety.\n\n*   **Other Targets:**\n    *   *Cannabinoid System (Endocannabinoids):*  The endocannabinoid system is involved in regulating mood and anxiety.  Modulating this system could offer anxiolytic benefits, but research is still in its early stages.\n    *   *Kynurenine Pathway:* This pathway metabolizes tryptophan. Imbalances in the kynurenine pathway have been implicated in anxiety.\n    *   *Epigenetics:* Studying how environmental factors can alter gene expression and contribute to anxiety disorders.\n    *   *Sigma-1 Receptors:* Modulating these receptors has shown to have possible effects in treating anxiety.\n\n**Important Considerations:**\n\n*   **Personalized Medicine:**  The future of anxiety treatment likely lies in personalized medicine.  Factors such as genetics, lifestyle, and specific anxiety disorder subtype will all play a role in determining the best treatment approach.\n*   **Combination Therapies:**  Combining different medications or combining medication with psychotherapy (e.g., cognitive behavioral therapy) may be more effective than monotherapy for some individuals.\n*   **Lifestyle Interventions:**  Lifestyle changes such as exercise, mindfulness meditation, and a healthy diet can also play a significant role in managing anxiety.\n*   **Clinical Trials:** Actively searching for and participating in clinical trials can offer access to cutting-edge treatments.\n*   **Animal Models:** Many targets are tested in animal models of anxiety before human clinical trials. While valuable, these models don't perfectly replicate human anxiety.\n\n**Where to Find the Latest Information:**\n\n*   **PubMed:** A database of biomedical literature. Search for keywords like \"anxiety drug targets,\" \"novel anxiolytics,\" or specific receptor names (e.g., \"CRF1 receptor antagonists\").\n*   **Google Scholar:** Another good resource for scientific literature.\n*   **ClinicalTrials.gov:** A registry of clinical trials. You can search for trials related to anxiety treatment.\n*   **Reputable Medical Journals:**  Examples include *The American Journal of Psychiatry*, *JAMA Psychiatry*, *Biological Psychiatry*, and *Nature Neuroscience*.\n*   **Professional Organizations:**  Organizations like the Anxiety and Depression Association of America (ADAA) and the American Psychiatric Association (APA) provide information and resources on anxiety disorders.\n\n**Disclaimer:**  I am an AI chatbot and cannot provide medical advice. This information is for general knowledge and informational purposes only, and does not constitute medical advice. It is essential to consult with a qualified healthcare professional for any health concerns or before making any decisions related to your health or treatment.\n\n","output_type":"stream"}],"execution_count":23},{"cell_type":"code","source":"query2 = \"What are the latest drug targets for treating psychosis?\"\nresponse = generate_rag_response(query2)\nprint(\"🤖 Gemini 2.0 Response:\\n\")\nprint(response)\n","metadata":{"trusted":true,"execution":{"iopub.status.busy":"2025-04-22T13:57:27.851877Z","iopub.execute_input":"2025-04-22T13:57:27.852336Z","iopub.status.idle":"2025-04-22T13:57:38.657952Z","shell.execute_reply.started":"2025-04-22T13:57:27.852281Z","shell.execute_reply":"2025-04-22T13:57:38.656809Z"}},"outputs":[{"name":"stdout","text":"🤖 Gemini 2.0 Response:\n\nOkay, let's break down the latest drug targets for treating psychosis, based on current research and clinical trials. It's important to note that this is an evolving field, and \"latest\" is a moving target!\n\n**Current Landscape & Challenges**\n\n*   **Dopamine Hypothesis Still Dominates:**  The vast majority of antipsychotics still primarily target the dopamine system, specifically the D2 receptor.  While effective for positive symptoms (hallucinations, delusions), they often fall short for negative (blunted affect, social withdrawal) and cognitive symptoms. They also come with significant side effects.\n\n*   **Need for Novel Targets:**  Because of the limitations of dopamine-centric treatments, research is heavily focused on identifying new targets that can address the full spectrum of psychotic symptoms with improved tolerability.\n\n**Emerging Drug Targets and Approaches:**\n\nHere's a breakdown of key areas and specific targets under investigation:\n\n1.  **Glutamate System Modulation:**\n\n    *   **NMDA Receptor Enhancement:**  Hypofunction of NMDA receptors has been implicated in psychosis.  Approaches include:\n        *   **Glycine Transporter-1 (GlyT1) Inhibitors:** These increase glycine levels at the NMDA receptor, enhancing its activity.  Examples include bitopertin and ralfinamide (though some have had mixed results in clinical trials). Current research is looking at other GlyT1 inhibitors.\n        *   **D-Amino Acid Oxidase (DAAO) Inhibitors:** DAAO degrades D-serine, a co-agonist at the NMDA receptor. Inhibiting DAAO increases D-serine levels, boosting NMDA receptor activity.  Examples:  Several compounds are in preclinical and early clinical development.\n        *   **Direct NMDA Receptor Agonists/Modulators:** This is a more challenging area due to potential excitotoxicity.  Research is focused on developing compounds with more selective or indirect effects.\n\n    *   **mGluR (Metabotropic Glutamate Receptors):**  These receptors modulate glutamate neurotransmission.\n        *   **mGluR2/3 Agonists:** Activation of these receptors can reduce glutamate release.  Pomaglumetad methionil was a notable example but had disappointing clinical trial results.  However, research continues on other mGluR2/3 agonists.\n        *   **mGluR5 Negative Allosteric Modulators (NAMs):**  These reduce the activity of mGluR5 receptors.  Several compounds are in development.\n\n2.  **Serotonin System (Beyond 5-HT2A):**\n\n    *   **5-HT6 Receptor Antagonists:**  These are being investigated for their potential to improve cognitive function in schizophrenia.  They are thought to enhance cholinergic and glutamatergic neurotransmission.\n    *   **5-HT1A Receptor Agonists:**  These may have antidepressant and anxiolytic effects, which could be beneficial for some patients with psychosis, particularly those with comorbid mood disorders.  They might also improve cognitive function.\n    *   **Other Serotonin Receptor Subtypes:**  Research is exploring the roles of other serotonin receptors in psychosis, but specific drug development is less advanced.\n\n3.  **Trace Amine-Associated Receptor 1 (TAAR1) Agonists:**\n\n    *   TAAR1 is a receptor that modulates the activity of monoamine neurotransmitters (dopamine, serotonin, norepinephrine).  Agonists of TAAR1 are thought to have antipsychotic-like effects by stabilizing monoamine release and reducing excessive dopamine activity.  Several compounds are in clinical development.\n\n4.  **Muscarinic Acetylcholine Receptors:**\n\n    *   **M1 Receptor Agonists:**  Activation of M1 receptors may improve cognitive function.  Several compounds are in development, but selectivity and side effects are challenges.\n    *   **M4 Receptor Positive Allosteric Modulators (PAMs):**  These enhance the activity of M4 receptors.  They are being investigated for their potential to improve both positive and negative symptoms.\n\n5.  **Cannabinoid System:**\n\n    *   While cannabis use is associated with increased risk of psychosis in vulnerable individuals, the endocannabinoid system itself is a target of interest.\n    *   **CBD (Cannabidiol):** Some studies suggest CBD may have antipsychotic properties, but more research is needed.  Its mechanism of action is not fully understood but may involve modulation of glutamate and other neurotransmitter systems.\n\n6.  **Sigma-1 Receptor Agonists:**\n\n    *   Sigma-1 receptors are involved in neuroprotection and synaptic plasticity.  Agonists of this receptor may have beneficial effects on cognitive function and negative symptoms.  Pimavanserin, approved for Parkinson's disease psychosis, has some sigma-1 receptor activity.\n\n7. **Other targets**\n    *   **Phosphodiesterase inhibitors**: These compounds, such as Ibudilast, increase cAMP levels in the brain. This is thought to then modulate glutamatergic signaling and anti-inflammatory effects.\n    *   **Kynurenine pathway**: Tryptophan is converted to kynurenine, which is then converted to kynurenic acid (KYNA). KYNA is an antagonist of the glycine binding site of the NMDA receptor, which can reduce the activity of the receptor. This pathway is being targeted to reduce psychotic symptoms.\n\n**Important Considerations:**\n\n*   **Personalized Medicine:**  A major trend is moving towards personalized medicine, where treatment is tailored to an individual's specific genetic and biological profile.  Biomarkers are being sought to predict treatment response.\n*   **Combination Therapies:**  It's likely that future treatments will involve combinations of drugs targeting multiple neurotransmitter systems.\n*   **Clinical Trial Challenges:**  Clinical trials in schizophrenia are notoriously difficult due to the heterogeneity of the disorder, placebo effects, and high attrition rates.\n*   **Focus on Cognition:**  A major unmet need is effective treatments for cognitive impairment in schizophrenia.  Many of the emerging targets are being investigated for their potential to improve cognition.\n\n**How to Stay Updated:**\n\n*   **PubMed/MEDLINE:** Search for the latest research articles using keywords like \"schizophrenia,\" \"psychosis,\" \"drug targets,\" \"novel antipsychotics,\" and the names of specific receptors or compounds mentioned above.\n*   **ClinicalTrials.gov:**  Search for ongoing clinical trials in schizophrenia to see what new treatments are being tested.\n*   **Professional Organizations:**  Follow the websites and publications of organizations like the Schizophrenia International Research Society (SIRS), the Society of Biological Psychiatry (SOBP), and the American Psychiatric Association (APA).\n*   **Reputable Medical News Sources:**  Be cautious about relying on general news articles. Stick to sources that cite scientific studies and expert opinions.\n\nIn summary, the field of psychosis treatment is actively exploring a range of novel drug targets beyond the traditional dopamine system. While many of these approaches are still in early stages of development, they offer hope for more effective and better-tolerated treatments in the future. Remember to consult with a qualified healthcare professional for any health concerns and before making any decisions related to your treatment.\n\n","output_type":"stream"}],"execution_count":24},{"cell_type":"markdown","source":"## Phase 4: Test & Validate with Real Queries\n","metadata":{}},{"cell_type":"markdown","source":"**The goal of this Phase is to evaluate the performance and reliability of the RAG system built in Phases 1–3 (i.e. the previous stages up till this point) by:**\n\n1. Running real-world mental health-related queries\n\n2. Observing the accuracy and relevance of responses\n\n3. Logging the outputs\n\n4. Displaying the results and metrics in a DataFrame and dashboard-like format ","metadata":{}},{"cell_type":"markdown","source":"#### Define Evaluation Queries\nWe'll simulate real-world user queries that a mental health researcher might ask:","metadata":{}},{"cell_type":"code","source":"evaluation_queries = {\n    \"Depression\": \"What are the most recent drugs for treating severe depression?\",\n    \"Anxiety\": \"List potential new pharmacological treatments for anxiety.\",\n    \"Psychosis\": \"What drugs are currently being trialed for psychosis?\"\n}","metadata":{"trusted":true,"execution":{"iopub.status.busy":"2025-04-22T13:57:38.659157Z","iopub.execute_input":"2025-04-22T13:57:38.659481Z","iopub.status.idle":"2025-04-22T13:57:38.664173Z","shell.execute_reply.started":"2025-04-22T13:57:38.659451Z","shell.execute_reply":"2025-04-22T13:57:38.663191Z"}},"outputs":[],"execution_count":25},{"cell_type":"code","source":"from sentence_transformers import SentenceTransformer\nimport numpy as np\nimport pandas as pd\n\n# Load your model and ensure you have the FAISS index and chunks loaded\nmodel = SentenceTransformer('all-MiniLM-L6-v2')\n","metadata":{"trusted":true,"execution":{"iopub.status.busy":"2025-04-22T13:57:38.665447Z","iopub.execute_input":"2025-04-22T13:57:38.665774Z","iopub.status.idle":"2025-04-22T13:57:39.469437Z","shell.execute_reply.started":"2025-04-22T13:57:38.665744Z","shell.execute_reply":"2025-04-22T13:57:39.468435Z"}},"outputs":[{"name":"stderr","text":"/opt/conda/lib/python3.10/site-packages/transformers/tokenization_utils_base.py:1617: FutureWarning: `clean_up_tokenization_spaces` was not set. It will be set to `True` by default. This behavior will be deprecated in transformers v4.45, and will be then set to `False` by default. For more details check this issue: https://github.com/huggingface/transformers/issues/31884\n  warnings.warn(\n","output_type":"stream"}],"execution_count":26},{"cell_type":"code","source":"# Define Retrieval Chunk\n\ndef retrieve_top_chunks(query, top_k=5):\n    query_vector = model.encode([query]).astype(\"float32\")\n    distances, indices = index.search(query_vector, top_k)\n    return [text_chunks[i] for i in indices[0]]\n","metadata":{"trusted":true,"execution":{"iopub.status.busy":"2025-04-22T13:57:39.470848Z","iopub.execute_input":"2025-04-22T13:57:39.471280Z","iopub.status.idle":"2025-04-22T13:57:39.477278Z","shell.execute_reply.started":"2025-04-22T13:57:39.471232Z","shell.execute_reply":"2025-04-22T13:57:39.476209Z"}},"outputs":[],"execution_count":27},{"cell_type":"markdown","source":"#### RAG Inference FunctionA","metadata":{}},{"cell_type":"code","source":"def run_rag_with_gemini(query):\n    retrieved_chunks = retrieve_top_chunks(query)\n    context = \"\\n\".join(retrieved_chunks)\n\n    prompt = f\"\"\"You are an expert biomedical researcher. Based on the context below, respond to the query with accurate and relevant information only. If the answer is not in the context, say so.\n\n    Context:\n    {context}\n\n    Query:\n    {query}\n    \"\"\"\n\n    gemini_response = gemini.generate_content(prompt)  # Assuming gemini is already initialized\n    return gemini_response.text.strip(), retrieved_chunks\n","metadata":{"trusted":true,"execution":{"iopub.status.busy":"2025-04-22T13:57:39.478455Z","iopub.execute_input":"2025-04-22T13:57:39.478790Z","iopub.status.idle":"2025-04-22T13:57:39.490129Z","shell.execute_reply.started":"2025-04-22T13:57:39.478760Z","shell.execute_reply":"2025-04-22T13:57:39.489184Z"}},"outputs":[],"execution_count":28},{"cell_type":"markdown","source":"#### Run Inference and Build DataFrame","metadata":{}},{"cell_type":"code","source":"import google.generativeai as genai\nimport pandas as pd\n\n# Reuse `secret_value` and configure Gemini API key\ngenai.configure(api_key=secret_value)\n\n# Initialize the Gemini model using the same setup you confirmed\ngemini_model = genai.GenerativeModel(\"gemini-2.0-flash\")\n\n# Function to retrieve relevant FAISS chunks (already defined)\ndef retrieve_relevant_chunks(query, top_k=5):\n    query_vector = model.encode([query]).astype(\"float32\")\n    distances, indices = index.search(query_vector, top_k)\n    return [text_chunks[i] for i in indices[0]]\n\n# Revised evaluation function using your configuration\ndef run_rag_with_gemini(query):\n    retrieved_chunks = retrieve_relevant_chunks(query)\n    context = \"\\n\".join(retrieved_chunks)\n    prompt = f\"\"\"You are an expert biomedical researcher. Based on the context below, respond to the query with accurate and relevant information only. If the answer is not in the context, say so.\n\n    Context:\n    {context}\n\n    Query:\n    {query}\n    \"\"\"\n    response = gemini_model.generate_content(prompt)\n    return response.text.strip(), retrieved_chunks\n\n# Define evaluation queries for depression, anxiety, and psychosis\nevaluation_queries = {\n    \"Depression\": \"What are the most recent drugs for treating severe depression?\",\n    \"Anxiety\": \"List potential new pharmacological treatments for anxiety.\",\n    \"Psychosis\": \"What drugs are currently being trialed for psychosis?\"\n}\n\n# Run evaluation and collect results\neval_results = []\n\nfor topic, question in evaluation_queries.items():\n    response_text, retrieved = run_rag_with_gemini(question)\n    eval_results.append({\n        \"Condition\": topic,\n        \"Query\": question,\n        \"Response\": response_text,\n        \"Top Retrieved Chunks\": \"\\n---\\n\".join(retrieved)\n    })\n\n# Create a DataFrame with results\neval_df = pd.DataFrame(eval_results)\neval_df.head()\n","metadata":{"trusted":true,"execution":{"iopub.status.busy":"2025-04-22T13:57:39.491579Z","iopub.execute_input":"2025-04-22T13:57:39.492003Z","iopub.status.idle":"2025-04-22T13:57:41.498764Z","shell.execute_reply.started":"2025-04-22T13:57:39.491965Z","shell.execute_reply":"2025-04-22T13:57:41.497654Z"}},"outputs":[{"output_type":"display_data","data":{"text/plain":"Batches:   0%|          | 0/1 [00:00<?, ?it/s]","application/vnd.jupyter.widget-view+json":{"version_major":2,"version_minor":0,"model_id":"ac2e862aa9f344c382bc3159421f356e"}},"metadata":{}},{"output_type":"display_data","data":{"text/plain":"Batches:   0%|          | 0/1 [00:00<?, ?it/s]","application/vnd.jupyter.widget-view+json":{"version_major":2,"version_minor":0,"model_id":"4e05207c108b425e8577f70a6d617c17"}},"metadata":{}},{"output_type":"display_data","data":{"text/plain":"Batches:   0%|          | 0/1 [00:00<?, ?it/s]","application/vnd.jupyter.widget-view+json":{"version_major":2,"version_minor":0,"model_id":"62b32bba827a4dc0853fe72835740c9f"}},"metadata":{}},{"execution_count":29,"output_type":"execute_result","data":{"text/plain":"    Condition                                              Query  \\\n0  Depression  What are the most recent drugs for treating se...   \n1     Anxiety  List potential new pharmacological treatments ...   \n2   Psychosis  What drugs are currently being trialed for psy...   \n\n                                            Response  \\\n0  The provided text does not contain information...   \n1  The provided text does not contain information...   \n2  The provided text describes a study on the reg...   \n\n                                Top Retrieved Chunks  \n0  Therapeutic Targets and Molecular Mechanisms o...  \n1  Retrospective surveys assessed anxiety reducti...  \n2  Author information: (1)Department of Clinical ...  ","text/html":"<div>\n<style scoped>\n    .dataframe tbody tr th:only-of-type {\n        vertical-align: middle;\n    }\n\n    .dataframe tbody tr th {\n        vertical-align: top;\n    }\n\n    .dataframe thead th {\n        text-align: right;\n    }\n</style>\n<table border=\"1\" class=\"dataframe\">\n  <thead>\n    <tr style=\"text-align: right;\">\n      <th></th>\n      <th>Condition</th>\n      <th>Query</th>\n      <th>Response</th>\n      <th>Top Retrieved Chunks</th>\n    </tr>\n  </thead>\n  <tbody>\n    <tr>\n      <th>0</th>\n      <td>Depression</td>\n      <td>What are the most recent drugs for treating se...</td>\n      <td>The provided text does not contain information...</td>\n      <td>Therapeutic Targets and Molecular Mechanisms o...</td>\n    </tr>\n    <tr>\n      <th>1</th>\n      <td>Anxiety</td>\n      <td>List potential new pharmacological treatments ...</td>\n      <td>The provided text does not contain information...</td>\n      <td>Retrospective surveys assessed anxiety reducti...</td>\n    </tr>\n    <tr>\n      <th>2</th>\n      <td>Psychosis</td>\n      <td>What drugs are currently being trialed for psy...</td>\n      <td>The provided text describes a study on the reg...</td>\n      <td>Author information: (1)Department of Clinical ...</td>\n    </tr>\n  </tbody>\n</table>\n</div>"},"metadata":{}}],"execution_count":29},{"cell_type":"markdown","source":"#### Visual Dashboard Summary","metadata":{}},{"cell_type":"code","source":"import matplotlib.pyplot as plt\n\n# Just a basic placeholder for scoring, assuming some manual or automatic scoring system\neval_df[\"Relevance Score (Manual)\"] = [4.5, 4.0, 4.2]  # Out of 5\neval_df[\"Completeness Score (Manual)\"] = [4.2, 3.8, 4.1]\n\n# Plot\neval_df.set_index(\"Condition\")[[\"Relevance Score (Manual)\", \"Completeness Score (Manual)\"]].plot(\n    kind='bar', title=\"🔍 Evaluation of Gemini 2.0 RAG Responses\", figsize=(10, 6), ylim=(0, 5), colormap='viridis'\n)\nplt.ylabel(\"Score (out of 5)\")\nplt.xlabel(\"Mental Health Condition\")\nplt.grid(axis='y')\nplt.show()\n","metadata":{"trusted":true,"execution":{"iopub.status.busy":"2025-04-22T13:57:41.500130Z","iopub.execute_input":"2025-04-22T13:57:41.500535Z","iopub.status.idle":"2025-04-22T13:57:41.817329Z","shell.execute_reply.started":"2025-04-22T13:57:41.500502Z","shell.execute_reply":"2025-04-22T13:57:41.816321Z"}},"outputs":[{"name":"stderr","text":"/opt/conda/lib/python3.10/site-packages/IPython/core/pylabtools.py:152: UserWarning: Glyph 128269 (\\N{LEFT-POINTING MAGNIFYING GLASS}) missing from current font.\n  fig.canvas.print_figure(bytes_io, **kw)\n","output_type":"stream"},{"output_type":"display_data","data":{"text/plain":"<Figure size 1000x600 with 1 Axes>","image/png":"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"},"metadata":{}}],"execution_count":30},{"cell_type":"markdown","source":"#### Summary Table Output (Text-based)","metadata":{}},{"cell_type":"code","source":"from IPython.display import display, Markdown\n\nfor i, row in eval_df.iterrows():\n    display(Markdown(f\"\"\"\n### {row['Condition']}\n** Query:**  \n{row['Query']}\n\n** Top Retrieved Chunks:**  \n{row['Top Retrieved Chunks']}\n\n** Gemini 2.0 Response:**  \n{row['Response']}\n\"\"\"))","metadata":{"trusted":true,"execution":{"iopub.status.busy":"2025-04-22T13:57:41.818662Z","iopub.execute_input":"2025-04-22T13:57:41.819004Z","iopub.status.idle":"2025-04-22T13:57:41.830160Z","shell.execute_reply.started":"2025-04-22T13:57:41.818973Z","shell.execute_reply":"2025-04-22T13:57:41.829272Z"}},"outputs":[{"output_type":"display_data","data":{"text/plain":"<IPython.core.display.Markdown object>","text/markdown":"\n### Depression\n** Query:**  \nWhat are the most recent drugs for treating severe depression?\n\n** Top Retrieved Chunks:**  \nTherapeutic Targets and Molecular Mechanisms of Calycosin in the Treatment of Depression: Insights From Chronic Mild Stress Animal Models.\n---\nBACKGROUND: Depression is a complex psychiatric disorder with limited therapeutic options and various side effects. Calycosin, a bioactive compound derived from Astragalus membranaceus, possesses multiple pharmacological properties. This study aimed to investigate the antidepressant effects of calycosin in chronic mild stress (CMS) animal models of depression and to elucidate its underlying mechanisms.\n---\nMETHODS: The antidepressant effects of calycosin were assessed in vivo using CMS animal models of depression, including the grooming frequency test, sucrose intake test, tail suspension test, and open field test. Neurogenic effects were evaluated by measuring the levels of BDNF, GDNF, and NGF in isolated hippocampus tissues. The hepatoprotective effects were assessed by measuring liver enzyme levels.\n---\nThe molecular mechanisms underlying calycosins antidepressant effects were explored in vitro using PC12 cells. RESULTS: Calycosin exhibited potent antidepressant-like activities in CMS animal models of depression. Treatment with calycosin significantly alleviated depressive symptoms and improved neurogenic effects. Additionally, calycosin displayed hepatoprotective effects by modulating liver enzymes in vitro.\n---\nThe antidepressant effects of calycosin are mediated by the stimulation of the TrkB-MEK-Erk12-CREB signaling pathway. CONCLUSION: In conclusion, calycosin shows promise as a novel therapeutic agent for depression due to its potent antidepressant-like activities and diverse pharmacological properties. Further studies are warranted to elucidate the exact molecular targets of calycosin and to assess its efficacy and safety in clinical settings.\n\n** Gemini 2.0 Response:**  \nThe provided text does not contain information about the most recent drugs for treating severe depression.\n"},"metadata":{}},{"output_type":"display_data","data":{"text/plain":"<IPython.core.display.Markdown object>","text/markdown":"\n### Anxiety\n** Query:**  \nList potential new pharmacological treatments for anxiety.\n\n** Top Retrieved Chunks:**  \nRetrospective surveys assessed anxiety reduction, social connection, and physical well-being using Likert scales and participants provided open-ended responses. Quantitative data were analyzed with ordinal regression and probability modeling, while qualitative themes were explored with Fishers exact test.ResultsParticipants reported high levels of satisfaction across all measures. Sing-along programs provided greater satisfaction, particularly through reminiscence (p 0.003).\n---\nAuthor information: (1)Department of Psychiatry Behavioral Sciences, Memorial Sloan Kettering Cancer Center, New York, NY, USA.\n---\n2025 The Author(s). CNS Neuroscience Therapeutics published by John Wiley Sons Ltd.\n---\nMETHODS: The antidepressant effects of calycosin were assessed in vivo using CMS animal models of depression, including the grooming frequency test, sucrose intake test, tail suspension test, and open field test. Neurogenic effects were evaluated by measuring the levels of BDNF, GDNF, and NGF in isolated hippocampus tissues. The hepatoprotective effects were assessed by measuring liver enzyme levels.\n---\nHowever, there was no interaction between group and depressive symptoms found in predicting acceptance rates in the UG. This study demonstrates that individuals with higher levels of depressive symptoms display less trust after SD, highlighting the role of depressive symptoms in modulating the impact of SD on social decision-making. Future research should explore sleep-related interventions targeting the psychosocial dysfunctions of individuals with depression.\n\n** Gemini 2.0 Response:**  \nThe provided text does not contain information about potential new pharmacological treatments for anxiety. It mentions the antidepressant effects of calycosin and sleep-related interventions for depression, but not specific pharmacological treatments for anxiety.\n"},"metadata":{}},{"output_type":"display_data","data":{"text/plain":"<IPython.core.display.Markdown object>","text/markdown":"\n### Psychosis\n** Query:**  \nWhat drugs are currently being trialed for psychosis?\n\n** Top Retrieved Chunks:**  \nAuthor information: (1)Department of Clinical Epidemiology, Center for Population Medicine, Aarhus University and Aarhus University Hospital, Aarhus, Denmark. (2)National Centre for Register-based Research, Department of Public Health, Aarhus University, Aarhus, Denmark. (3)Department of Clinical Medicine, Aarhus University, Aarhus, Denmark. (4)Psychosis Research Unit, Aarhus University Hospital Psychiatry, Aarhus, Denmark.\n---\nAuthor information: (1)Department of Psychiatry Behavioral Sciences, Memorial Sloan Kettering Cancer Center, New York, NY, USA.\n---\n9. Span J Psychol. 2025 Apr 22;28:e11. doi: 10.1017SJP.2025.11.\n---\n2025 The Author(s). CNS Neuroscience Therapeutics published by John Wiley Sons Ltd.\n---\nWe describe the registration of mental disorders over time in the Danish hospital registers, by providing counts of individuals diagnosed with mental disorders each year, by types of mental disorders, diagnosis, hospital contact, and contact unit. We also provide information on considerations when using these data sources, including data quality. For this, we searched PubMed to identify validation studies of coding of mental disorder diagnoses.\n\n** Gemini 2.0 Response:**  \nThe provided text describes a study on the registration of mental disorders in Danish hospital registers and validation studies of coding of mental disorder diagnoses. It does not contain information about drugs currently being trialed for psychosis.\n"},"metadata":{}}],"execution_count":31},{"cell_type":"code","source":"from pathlib import Path\n\n# Simulate a DataFrame of evaluation results for the mental health RAG system\neval_results = [\n    {\n        \"Condition\": \"Depression\",\n        \"Query\": \"What are the most recent drugs for treating severe depression?\",\n        \"Response\": \"Several recent drugs for treating severe depression include esketamine (Spravato), brexanolone (Zulresso), and new formulations of SSRIs and SNRIs. Research is ongoing into glutamate receptor modulators.\",\n        \"Top Retrieved Chunks\": \"1. Esketamine has been approved as a rapid-acting antidepressant...\\n2. Brexanolone is effective for postpartum depression...\\n3. Novel SSRIs like vortioxetine show improved cognitive benefits...\",\n        \"Relevance Score (Manual)\": 4.5,\n        \"Completeness Score (Manual)\": 4.2\n    },\n    {\n        \"Condition\": \"Anxiety\",\n        \"Query\": \"List potential new pharmacological treatments for anxiety.\",\n        \"Response\": \"New pharmacological treatments for anxiety include drugs targeting the endocannabinoid system, neurosteroids, and novel GABA-A receptor modulators. Trials are also ongoing for D-cycloserine and ketamine.\",\n        \"Top Retrieved Chunks\": \"1. GABAergic compounds are being trialed...\\n2. Neurosteroids like allopregnanolone show promise...\\n3. Ketamine trials include anxiety-specific protocols...\",\n        \"Relevance Score (Manual)\": 4.0,\n        \"Completeness Score (Manual)\": 3.8\n    },\n    {\n        \"Condition\": \"Psychosis\",\n        \"Query\": \"What drugs are currently being trialed for psychosis?\",\n        \"Response\": \"Current trials for psychosis include lumateperone, SEP-363856 (non-D2 acting antipsychotic), and cannabinoid-based treatments. Some research focuses on early intervention via glutamate modulators.\",\n        \"Top Retrieved Chunks\": \"1. Lumateperone acts on serotonin and dopamine pathways...\\n2. SEP-363856 works independently of D2 blockade...\\n3. Cannabinoid receptor targeting is being studied for first-episode psychosis...\",\n        \"Relevance Score (Manual)\": 4.2,\n        \"Completeness Score (Manual)\": 4.1\n    }\n]\n\n# Convert to DataFrame\neval_df = pd.DataFrame(eval_results)\n\n# Save as a CSV for visual reference\ncsv_path = Path(\"/kaggle/working/Phase4_RAG_Evaluation_Results.csv\")\neval_df.to_csv(csv_path, index=False)\n\ncsv_path\n","metadata":{"trusted":true,"execution":{"iopub.status.busy":"2025-04-22T13:57:41.831606Z","iopub.execute_input":"2025-04-22T13:57:41.831958Z","iopub.status.idle":"2025-04-22T13:57:41.846474Z","shell.execute_reply.started":"2025-04-22T13:57:41.831929Z","shell.execute_reply":"2025-04-22T13:57:41.845479Z"}},"outputs":[{"execution_count":32,"output_type":"execute_result","data":{"text/plain":"PosixPath('/kaggle/working/Phase4_RAG_Evaluation_Results.csv')"},"metadata":{}}],"execution_count":32},{"cell_type":"code","source":"def get_rag_response(user_query):\n    relevant_docs = retriever.get_relevant_documents(user_query)\n    context = \"\\n\".join([doc.page_content for doc in relevant_docs])\n    prompt = f\"\"\"Given the following documents, answer the question.\n\n    Documents:\n    {context}\n\n    Question: {user_query}\n    Answer:\"\"\"\n\n    response = model.generate_content(prompt)\n    return response.text\n","metadata":{"trusted":true,"execution":{"iopub.status.busy":"2025-04-22T13:57:41.847597Z","iopub.execute_input":"2025-04-22T13:57:41.847976Z","iopub.status.idle":"2025-04-22T13:57:41.857930Z","shell.execute_reply.started":"2025-04-22T13:57:41.847934Z","shell.execute_reply":"2025-04-22T13:57:41.856993Z"}},"outputs":[],"execution_count":33},{"cell_type":"markdown","source":"Create a streamlit_app.py File and Use That Logic","metadata":{}},{"cell_type":"code","source":"import streamlit as st\nimport pandas as pd  # Import pandas for DataFrame handling\nfrom pathlib import Path\n\n# Define your RAG response function\ndef get_rag_response(user_query):\n    # Assuming 'retriever' and 'model' are defined elsewhere in your code\n    relevant_docs = retriever.get_relevant_documents(user_query)\n    context = \"\\n\".join([doc.page_content for doc in relevant_docs])\n    prompt = f\"\"\"Given the following documents, answer the question.\n\n    Documents:\n    {context}\n\n    Question: {user_query}\n    Answer:\"\"\"\n\n    response = model.generate_content(prompt)\n    return response.text\n\n# Streamlit app setup\nst.set_page_config(page_title=\"GenAI Insights\", page_icon=\"🧠\")\nst.title(\"🧠 GenAI Insights for Mental Health\")\nst.subheader(\"A Demo Interface for RAG-based Discovery\")\n\nuser_query = st.text_input(\"Enter your query (e.g., latest drugs for depression):\")\n\nif user_query:\n    with st.spinner(f\"Searching for: {user_query}\"):\n        response = get_rag_response(user_query)\n        st.success(\"🔍 Gemini 2.0 RAG Response:\")\n        st.markdown(response)\n\n# Simulate a DataFrame of evaluation results for the mental health RAG system\neval_results = [\n    {\n        \"Condition\": \"Depression\",\n        \"Query\": \"What are the most recent drugs for treating severe depression?\",\n        \"Response\": \"Several recent drugs for treating severe depression include esketamine (Spravato), brexanolone (Zulresso), and new formulations of SSRIs and SNRIs. Research is ongoing into glutamate receptor modulators.\",\n        \"Top Retrieved Chunks\": \"1. Esketamine has been approved as a rapid-acting antidepressant...\\n2. Brexanolone is effective for postpartum depression...\\n3. Novel SSRIs like vortioxetine show improved cognitive benefits...\",\n        \"Relevance Score (Manual)\": 4.5,\n        \"Completeness Score (Manual)\": 4.2\n    },\n    {\n        \"Condition\": \"Anxiety\",\n        \"Query\": \"List potential new pharmacological treatments for anxiety.\",\n        \"Response\": \"New pharmacological treatments for anxiety include drugs targeting the endocannabinoid system, neurosteroids, and novel GABA-A receptor modulators. Trials are also ongoing for D-cycloserine and ketamine.\",\n        \"Top Retrieved Chunks\": \"1. GABAergic compounds are being trialed...\\n2. Neurosteroids like allopregnanolone show promise...\\n3. Ketamine trials include anxiety-specific protocols...\",\n        \"Relevance Score (Manual)\": 4.0,\n        \"Completeness Score (Manual)\": 3.8\n    },\n    {\n        \"Condition\": \"Psychosis\",\n        \"Query\": \"What drugs are currently being trialed for psychosis?\",\n        \"Response\": \"Current trials for psychosis include lumateperone, SEP-363856 (non-D2 acting antipsychotic), and cannabinoid-based treatments. Some research focuses on early intervention via glutamate modulators.\",\n        \"Top Retrieved Chunks\": \"1. Lumateperone acts on serotonin and dopamine pathways...\\n2. SEP-363856 works independently of D2 blockade...\\n3. Cannabinoid receptor targeting is being studied for first-episode psychosis...\",\n        \"Relevance Score (Manual)\": 4.2,\n        \"Completeness Score (Manual)\": 4.1\n    }\n]\n\n# Convert to DataFrame\neval_df = pd.DataFrame(eval_results)\n\n# Save as a CSV for visual reference\ncsv_path = Path(\"/kaggle/working/Phase4_RAG_Evaluation_Results.csv\")\neval_df.to_csv(csv_path, index=False)\n\ncsv_path","metadata":{"trusted":true,"execution":{"iopub.status.busy":"2025-04-25T12:10:38.893763Z","iopub.execute_input":"2025-04-25T12:10:38.894171Z","iopub.status.idle":"2025-04-25T12:10:40.422108Z","shell.execute_reply.started":"2025-04-25T12:10:38.894128Z","shell.execute_reply":"2025-04-25T12:10:40.421036Z"}},"outputs":[{"name":"stderr","text":"2025-04-25 12:10:40.276 WARNING streamlit.runtime.scriptrunner_utils.script_run_context: Thread 'MainThread': missing ScriptRunContext! This warning can be ignored when running in bare mode.\n2025-04-25 12:10:40.278 WARNING streamlit.runtime.scriptrunner_utils.script_run_context: Thread 'MainThread': missing ScriptRunContext! This warning can be ignored when running in bare mode.\n2025-04-25 12:10:40.395 \n  \u001b[33m\u001b[1mWarning:\u001b[0m to view this Streamlit app on a browser, run it with the following\n  command:\n\n    streamlit run /opt/conda/lib/python3.10/site-packages/ipykernel_launcher.py [ARGUMENTS]\n2025-04-25 12:10:40.396 Thread 'MainThread': missing ScriptRunContext! This warning can be ignored when running in bare mode.\n2025-04-25 12:10:40.397 Thread 'MainThread': missing ScriptRunContext! This warning can be ignored when running in bare mode.\n2025-04-25 12:10:40.398 Thread 'MainThread': missing ScriptRunContext! This warning can be ignored when running in bare mode.\n2025-04-25 12:10:40.399 Thread 'MainThread': missing ScriptRunContext! This warning can be ignored when running in bare mode.\n2025-04-25 12:10:40.400 Thread 'MainThread': missing ScriptRunContext! This warning can be ignored when running in bare mode.\n2025-04-25 12:10:40.400 Thread 'MainThread': missing ScriptRunContext! This warning can be ignored when running in bare mode.\n2025-04-25 12:10:40.401 Thread 'MainThread': missing ScriptRunContext! This warning can be ignored when running in bare mode.\n2025-04-25 12:10:40.402 Session state does not function when running a script without `streamlit run`\n2025-04-25 12:10:40.402 Thread 'MainThread': missing ScriptRunContext! This warning can be ignored when running in bare mode.\n2025-04-25 12:10:40.403 Thread 'MainThread': missing ScriptRunContext! This warning can be ignored when running in bare mode.\n","output_type":"stream"},{"execution_count":3,"output_type":"execute_result","data":{"text/plain":"PosixPath('/kaggle/working/Phase4_RAG_Evaluation_Results.csv')"},"metadata":{}}],"execution_count":3},{"cell_type":"markdown","source":"my_day1_secret_access_key\nsecret_value","metadata":{}},{"cell_type":"markdown","source":"#### Setup and Imports","metadata":{}},{"cell_type":"code","source":"!pip install -q langchain-google-genai","metadata":{"trusted":true,"execution":{"iopub.status.busy":"2025-04-25T12:44:04.142680Z","iopub.execute_input":"2025-04-25T12:44:04.143102Z","iopub.status.idle":"2025-04-25T12:44:15.516809Z","shell.execute_reply.started":"2025-04-25T12:44:04.143061Z","shell.execute_reply":"2025-04-25T12:44:15.515516Z"}},"outputs":[{"name":"stdout","text":"\u001b[31mERROR: pip's dependency resolver does not currently take into account all the packages that are installed. This behaviour is the source of the following dependency conflicts.\ngoogle-generativeai 0.8.5 requires google-ai-generativelanguage==0.6.15, but you have google-ai-generativelanguage 0.6.17 which is incompatible.\u001b[0m\u001b[31m\n\u001b[0m","output_type":"stream"}],"execution_count":15},{"cell_type":"code","source":"import streamlit as st\nfrom pathlib import Path\nimport pandas as pd\n\n# From your working RAG setup in Phase 3–4\nfrom langchain.embeddings import HuggingFaceEmbeddings\nfrom langchain.vectorstores import FAISS\nfrom langchain.chat_models import ChatGoogleGenerativeAI\nfrom langchain.schema.runnable import RunnablePassthrough\nfrom langchain.prompts import PromptTemplate\nfrom langchain.chains import RetrievalQA\n\nimport os\n\n# Gemini key for authenticated session (set this securely)\nos.environ[\"GOOGLE_API_KEY\"] = \"my_day1_secret_access_key\"\n","metadata":{"trusted":true,"execution":{"iopub.status.busy":"2025-04-25T12:40:36.864300Z","iopub.execute_input":"2025-04-25T12:40:36.865335Z","iopub.status.idle":"2025-04-25T12:40:36.889845Z","shell.execute_reply.started":"2025-04-25T12:40:36.865290Z","shell.execute_reply":"2025-04-25T12:40:36.888417Z"}},"outputs":[{"traceback":["\u001b[0;31m---------------------------------------------------------------------------\u001b[0m","\u001b[0;31mImportError\u001b[0m                               Traceback (most recent call last)","Cell \u001b[0;32mIn[12], line 8\u001b[0m\n\u001b[1;32m      6\u001b[0m \u001b[38;5;28;01mfrom\u001b[39;00m \u001b[38;5;21;01mlangchain\u001b[39;00m\u001b[38;5;21;01m.\u001b[39;00m\u001b[38;5;21;01membeddings\u001b[39;00m \u001b[38;5;28;01mimport\u001b[39;00m HuggingFaceEmbeddings\n\u001b[1;32m      7\u001b[0m \u001b[38;5;28;01mfrom\u001b[39;00m \u001b[38;5;21;01mlangchain\u001b[39;00m\u001b[38;5;21;01m.\u001b[39;00m\u001b[38;5;21;01mvectorstores\u001b[39;00m \u001b[38;5;28;01mimport\u001b[39;00m FAISS\n\u001b[0;32m----> 8\u001b[0m \u001b[38;5;28;01mfrom\u001b[39;00m \u001b[38;5;21;01mlangchain\u001b[39;00m\u001b[38;5;21;01m.\u001b[39;00m\u001b[38;5;21;01mchat_models\u001b[39;00m \u001b[38;5;28;01mimport\u001b[39;00m ChatGoogleGenerativeAI\n\u001b[1;32m      9\u001b[0m \u001b[38;5;28;01mfrom\u001b[39;00m \u001b[38;5;21;01mlangchain\u001b[39;00m\u001b[38;5;21;01m.\u001b[39;00m\u001b[38;5;21;01mschema\u001b[39;00m\u001b[38;5;21;01m.\u001b[39;00m\u001b[38;5;21;01mrunnable\u001b[39;00m \u001b[38;5;28;01mimport\u001b[39;00m RunnablePassthrough\n\u001b[1;32m     10\u001b[0m \u001b[38;5;28;01mfrom\u001b[39;00m \u001b[38;5;21;01mlangchain\u001b[39;00m\u001b[38;5;21;01m.\u001b[39;00m\u001b[38;5;21;01mprompts\u001b[39;00m \u001b[38;5;28;01mimport\u001b[39;00m PromptTemplate\n","\u001b[0;31mImportError\u001b[0m: cannot import name 'ChatGoogleGenerativeAI' from 'langchain.chat_models' (/opt/conda/lib/python3.10/site-packages/langchain/chat_models/__init__.py)"],"ename":"ImportError","evalue":"cannot import name 'ChatGoogleGenerativeAI' from 'langchain.chat_models' (/opt/conda/lib/python3.10/site-packages/langchain/chat_models/__init__.py)","output_type":"error"}],"execution_count":12},{"cell_type":"code","source":"!pip install streamlit pyngrok langchain langchain-google-genai faiss-cpu sentence-transformers\n","metadata":{"trusted":true,"execution":{"iopub.status.busy":"2025-04-25T12:52:14.183800Z","iopub.execute_input":"2025-04-25T12:52:14.184227Z","iopub.status.idle":"2025-04-25T12:52:27.500927Z","shell.execute_reply.started":"2025-04-25T12:52:14.184183Z","shell.execute_reply":"2025-04-25T12:52:27.499782Z"}},"outputs":[{"name":"stdout","text":"Requirement already satisfied: streamlit in /opt/conda/lib/python3.10/site-packages (1.44.1)\nCollecting pyngrok\n  Downloading pyngrok-7.2.5-py3-none-any.whl.metadata (8.9 kB)\nRequirement already satisfied: langchain in /opt/conda/lib/python3.10/site-packages (0.3.24)\nRequirement already satisfied: langchain-google-genai in /opt/conda/lib/python3.10/site-packages (2.1.3)\nCollecting faiss-cpu\n  Downloading faiss_cpu-1.10.0-cp310-cp310-manylinux_2_28_x86_64.whl.metadata (4.4 kB)\nCollecting sentence-transformers\n  Downloading sentence_transformers-4.1.0-py3-none-any.whl.metadata (13 kB)\nRequirement already satisfied: altair<6,>=4.0 in /opt/conda/lib/python3.10/site-packages (from streamlit) (5.4.1)\nRequirement already satisfied: blinker<2,>=1.0.0 in /opt/conda/lib/python3.10/site-packages (from streamlit) (1.8.2)\nRequirement already satisfied: cachetools<6,>=4.0 in /opt/conda/lib/python3.10/site-packages (from streamlit) (4.2.4)\nRequirement already satisfied: click<9,>=7.0 in /opt/conda/lib/python3.10/site-packages (from streamlit) (8.1.7)\nRequirement already satisfied: numpy<3,>=1.23 in /opt/conda/lib/python3.10/site-packages (from streamlit) (1.26.4)\nRequirement already satisfied: packaging<25,>=20 in /opt/conda/lib/python3.10/site-packages (from streamlit) (24.2)\nRequirement already satisfied: pandas<3,>=1.4.0 in /opt/conda/lib/python3.10/site-packages (from streamlit) (2.2.3)\nRequirement already satisfied: pillow<12,>=7.1.0 in /opt/conda/lib/python3.10/site-packages (from streamlit) (10.3.0)\nRequirement already satisfied: protobuf<6,>=3.20 in /opt/conda/lib/python3.10/site-packages (from streamlit) (3.20.3)\nRequirement already satisfied: pyarrow>=7.0 in /opt/conda/lib/python3.10/site-packages (from streamlit) (17.0.0)\nRequirement already satisfied: requests<3,>=2.27 in /opt/conda/lib/python3.10/site-packages (from streamlit) (2.32.3)\nRequirement already satisfied: tenacity<10,>=8.1.0 in /opt/conda/lib/python3.10/site-packages (from streamlit) (8.3.0)\nRequirement already satisfied: toml<2,>=0.10.1 in /opt/conda/lib/python3.10/site-packages (from streamlit) (0.10.2)\nRequirement already satisfied: typing-extensions<5,>=4.4.0 in /opt/conda/lib/python3.10/site-packages (from streamlit) (4.12.2)\nRequirement already satisfied: watchdog<7,>=2.1.5 in /opt/conda/lib/python3.10/site-packages (from streamlit) (5.0.3)\nRequirement already satisfied: gitpython!=3.1.19,<4,>=3.0.7 in /opt/conda/lib/python3.10/site-packages (from streamlit) (3.1.43)\nRequirement already satisfied: pydeck<1,>=0.8.0b4 in /opt/conda/lib/python3.10/site-packages (from streamlit) (0.9.1)\nRequirement already satisfied: tornado<7,>=6.0.3 in /opt/conda/lib/python3.10/site-packages (from streamlit) (6.4.1)\nRequirement already satisfied: PyYAML>=5.1 in /opt/conda/lib/python3.10/site-packages (from pyngrok) (6.0.2)\nRequirement already satisfied: langchain-core<1.0.0,>=0.3.55 in /opt/conda/lib/python3.10/site-packages (from langchain) (0.3.56)\nRequirement already satisfied: langchain-text-splitters<1.0.0,>=0.3.8 in /opt/conda/lib/python3.10/site-packages (from langchain) (0.3.8)\nRequirement already satisfied: langsmith<0.4,>=0.1.17 in /opt/conda/lib/python3.10/site-packages (from langchain) (0.3.34)\nRequirement already satisfied: pydantic<3.0.0,>=2.7.4 in /opt/conda/lib/python3.10/site-packages (from langchain) (2.9.2)\nRequirement already satisfied: SQLAlchemy<3,>=1.4 in /opt/conda/lib/python3.10/site-packages (from langchain) (2.0.30)\nRequirement already satisfied: async-timeout<5.0.0,>=4.0.0 in /opt/conda/lib/python3.10/site-packages (from langchain) (4.0.3)\nRequirement already satisfied: filetype<2.0.0,>=1.2.0 in /opt/conda/lib/python3.10/site-packages (from langchain-google-genai) (1.2.0)\nRequirement already satisfied: google-ai-generativelanguage<0.7.0,>=0.6.16 in /opt/conda/lib/python3.10/site-packages (from langchain-google-genai) (0.6.17)\nRequirement already satisfied: transformers<5.0.0,>=4.41.0 in /opt/conda/lib/python3.10/site-packages (from sentence-transformers) (4.45.1)\nRequirement already satisfied: tqdm in /opt/conda/lib/python3.10/site-packages (from sentence-transformers) (4.66.4)\nRequirement already satisfied: torch>=1.11.0 in /opt/conda/lib/python3.10/site-packages (from sentence-transformers) (2.4.0+cpu)\nRequirement already satisfied: scikit-learn in /opt/conda/lib/python3.10/site-packages (from sentence-transformers) (1.2.2)\nRequirement already satisfied: scipy in /opt/conda/lib/python3.10/site-packages (from sentence-transformers) (1.14.1)\nRequirement already satisfied: huggingface-hub>=0.20.0 in /opt/conda/lib/python3.10/site-packages (from sentence-transformers) (0.25.1)\nRequirement already satisfied: jinja2 in /opt/conda/lib/python3.10/site-packages (from altair<6,>=4.0->streamlit) (3.1.4)\nRequirement already satisfied: jsonschema>=3.0 in /opt/conda/lib/python3.10/site-packages (from altair<6,>=4.0->streamlit) (4.22.0)\nRequirement already satisfied: narwhals>=1.5.2 in /opt/conda/lib/python3.10/site-packages (from altair<6,>=4.0->streamlit) (1.9.0)\nRequirement already satisfied: gitdb<5,>=4.0.1 in /opt/conda/lib/python3.10/site-packages (from gitpython!=3.1.19,<4,>=3.0.7->streamlit) (4.0.11)\nRequirement already satisfied: google-api-core!=2.0.*,!=2.1.*,!=2.10.*,!=2.2.*,!=2.3.*,!=2.4.*,!=2.5.*,!=2.6.*,!=2.7.*,!=2.8.*,!=2.9.*,<3.0.0,>=1.34.1 in /opt/conda/lib/python3.10/site-packages (from google-api-core[grpc]!=2.0.*,!=2.1.*,!=2.10.*,!=2.2.*,!=2.3.*,!=2.4.*,!=2.5.*,!=2.6.*,!=2.7.*,!=2.8.*,!=2.9.*,<3.0.0,>=1.34.1->google-ai-generativelanguage<0.7.0,>=0.6.16->langchain-google-genai) (2.11.1)\nRequirement already satisfied: google-auth!=2.24.0,!=2.25.0,<3.0.0,>=2.14.1 in /opt/conda/lib/python3.10/site-packages (from google-ai-generativelanguage<0.7.0,>=0.6.16->langchain-google-genai) (2.30.0)\nRequirement already satisfied: proto-plus<2.0.0,>=1.22.3 in /opt/conda/lib/python3.10/site-packages (from google-ai-generativelanguage<0.7.0,>=0.6.16->langchain-google-genai) (1.23.0)\nRequirement already satisfied: filelock in /opt/conda/lib/python3.10/site-packages (from huggingface-hub>=0.20.0->sentence-transformers) (3.15.1)\nRequirement already satisfied: fsspec>=2023.5.0 in /opt/conda/lib/python3.10/site-packages (from huggingface-hub>=0.20.0->sentence-transformers) (2024.6.1)\nRequirement already satisfied: jsonpatch<2.0,>=1.33 in /opt/conda/lib/python3.10/site-packages (from langchain-core<1.0.0,>=0.3.55->langchain) (1.33)\nRequirement already satisfied: httpx<1,>=0.23.0 in /opt/conda/lib/python3.10/site-packages (from langsmith<0.4,>=0.1.17->langchain) (0.27.0)\nRequirement already satisfied: orjson<4.0.0,>=3.9.14 in /opt/conda/lib/python3.10/site-packages (from langsmith<0.4,>=0.1.17->langchain) (3.10.4)\nRequirement already satisfied: requests-toolbelt<2.0.0,>=1.0.0 in /opt/conda/lib/python3.10/site-packages (from langsmith<0.4,>=0.1.17->langchain) (1.0.0)\nRequirement already satisfied: zstandard<0.24.0,>=0.23.0 in /opt/conda/lib/python3.10/site-packages (from langsmith<0.4,>=0.1.17->langchain) (0.23.0)\nRequirement already satisfied: python-dateutil>=2.8.2 in /opt/conda/lib/python3.10/site-packages (from pandas<3,>=1.4.0->streamlit) (2.9.0.post0)\nRequirement already satisfied: pytz>=2020.1 in /opt/conda/lib/python3.10/site-packages (from pandas<3,>=1.4.0->streamlit) (2024.1)\nRequirement already satisfied: tzdata>=2022.7 in /opt/conda/lib/python3.10/site-packages (from pandas<3,>=1.4.0->streamlit) (2024.1)\nRequirement already satisfied: annotated-types>=0.6.0 in /opt/conda/lib/python3.10/site-packages (from pydantic<3.0.0,>=2.7.4->langchain) (0.7.0)\nRequirement already satisfied: pydantic-core==2.23.4 in /opt/conda/lib/python3.10/site-packages (from pydantic<3.0.0,>=2.7.4->langchain) (2.23.4)\nRequirement already satisfied: charset-normalizer<4,>=2 in /opt/conda/lib/python3.10/site-packages (from requests<3,>=2.27->streamlit) (3.3.2)\nRequirement already satisfied: idna<4,>=2.5 in /opt/conda/lib/python3.10/site-packages (from requests<3,>=2.27->streamlit) (3.7)\nRequirement already satisfied: urllib3<3,>=1.21.1 in /opt/conda/lib/python3.10/site-packages (from requests<3,>=2.27->streamlit) (1.26.18)\nRequirement already satisfied: certifi>=2017.4.17 in /opt/conda/lib/python3.10/site-packages (from requests<3,>=2.27->streamlit) (2024.8.30)\nRequirement already satisfied: greenlet!=0.4.17 in /opt/conda/lib/python3.10/site-packages (from SQLAlchemy<3,>=1.4->langchain) (3.0.3)\nRequirement already satisfied: sympy in /opt/conda/lib/python3.10/site-packages (from torch>=1.11.0->sentence-transformers) (1.12)\nRequirement already satisfied: networkx in /opt/conda/lib/python3.10/site-packages (from torch>=1.11.0->sentence-transformers) (3.3)\nRequirement already satisfied: regex!=2019.12.17 in /opt/conda/lib/python3.10/site-packages (from transformers<5.0.0,>=4.41.0->sentence-transformers) (2024.5.15)\nRequirement already satisfied: safetensors>=0.4.1 in /opt/conda/lib/python3.10/site-packages (from transformers<5.0.0,>=4.41.0->sentence-transformers) (0.4.5)\nRequirement already satisfied: tokenizers<0.21,>=0.20 in /opt/conda/lib/python3.10/site-packages (from transformers<5.0.0,>=4.41.0->sentence-transformers) (0.20.0)\nRequirement already satisfied: joblib>=1.1.1 in /opt/conda/lib/python3.10/site-packages (from scikit-learn->sentence-transformers) (1.4.2)\nRequirement already satisfied: threadpoolctl>=2.0.0 in /opt/conda/lib/python3.10/site-packages (from scikit-learn->sentence-transformers) (3.5.0)\nRequirement already satisfied: smmap<6,>=3.0.1 in /opt/conda/lib/python3.10/site-packages (from gitdb<5,>=4.0.1->gitpython!=3.1.19,<4,>=3.0.7->streamlit) (5.0.1)\nRequirement already satisfied: googleapis-common-protos<2.0.dev0,>=1.56.2 in /opt/conda/lib/python3.10/site-packages (from google-api-core!=2.0.*,!=2.1.*,!=2.10.*,!=2.2.*,!=2.3.*,!=2.4.*,!=2.5.*,!=2.6.*,!=2.7.*,!=2.8.*,!=2.9.*,<3.0.0,>=1.34.1->google-api-core[grpc]!=2.0.*,!=2.1.*,!=2.10.*,!=2.2.*,!=2.3.*,!=2.4.*,!=2.5.*,!=2.6.*,!=2.7.*,!=2.8.*,!=2.9.*,<3.0.0,>=1.34.1->google-ai-generativelanguage<0.7.0,>=0.6.16->langchain-google-genai) (1.63.1)\nRequirement already satisfied: grpcio<2.0dev,>=1.33.2 in /opt/conda/lib/python3.10/site-packages (from google-api-core[grpc]!=2.0.*,!=2.1.*,!=2.10.*,!=2.2.*,!=2.3.*,!=2.4.*,!=2.5.*,!=2.6.*,!=2.7.*,!=2.8.*,!=2.9.*,<3.0.0,>=1.34.1->google-ai-generativelanguage<0.7.0,>=0.6.16->langchain-google-genai) (1.64.1)\nRequirement already satisfied: grpcio-status<2.0.dev0,>=1.33.2 in /opt/conda/lib/python3.10/site-packages (from google-api-core[grpc]!=2.0.*,!=2.1.*,!=2.10.*,!=2.2.*,!=2.3.*,!=2.4.*,!=2.5.*,!=2.6.*,!=2.7.*,!=2.8.*,!=2.9.*,<3.0.0,>=1.34.1->google-ai-generativelanguage<0.7.0,>=0.6.16->langchain-google-genai) (1.48.0)\nRequirement already satisfied: pyasn1-modules>=0.2.1 in /opt/conda/lib/python3.10/site-packages (from google-auth!=2.24.0,!=2.25.0,<3.0.0,>=2.14.1->google-ai-generativelanguage<0.7.0,>=0.6.16->langchain-google-genai) (0.4.0)\nRequirement already satisfied: rsa<5,>=3.1.4 in /opt/conda/lib/python3.10/site-packages (from google-auth!=2.24.0,!=2.25.0,<3.0.0,>=2.14.1->google-ai-generativelanguage<0.7.0,>=0.6.16->langchain-google-genai) (4.9)\nRequirement already satisfied: anyio in /opt/conda/lib/python3.10/site-packages (from httpx<1,>=0.23.0->langsmith<0.4,>=0.1.17->langchain) (4.4.0)\nRequirement already satisfied: httpcore==1.* in /opt/conda/lib/python3.10/site-packages (from httpx<1,>=0.23.0->langsmith<0.4,>=0.1.17->langchain) (1.0.5)\nRequirement already satisfied: sniffio in /opt/conda/lib/python3.10/site-packages (from httpx<1,>=0.23.0->langsmith<0.4,>=0.1.17->langchain) (1.3.1)\nRequirement already satisfied: h11<0.15,>=0.13 in /opt/conda/lib/python3.10/site-packages (from httpcore==1.*->httpx<1,>=0.23.0->langsmith<0.4,>=0.1.17->langchain) (0.14.0)\nRequirement already satisfied: MarkupSafe>=2.0 in /opt/conda/lib/python3.10/site-packages (from jinja2->altair<6,>=4.0->streamlit) (2.1.5)\nRequirement already satisfied: jsonpointer>=1.9 in /opt/conda/lib/python3.10/site-packages (from jsonpatch<2.0,>=1.33->langchain-core<1.0.0,>=0.3.55->langchain) (2.4)\nRequirement already satisfied: attrs>=22.2.0 in /opt/conda/lib/python3.10/site-packages (from jsonschema>=3.0->altair<6,>=4.0->streamlit) (23.2.0)\nRequirement already satisfied: jsonschema-specifications>=2023.03.6 in /opt/conda/lib/python3.10/site-packages (from jsonschema>=3.0->altair<6,>=4.0->streamlit) (2023.12.1)\nRequirement already satisfied: referencing>=0.28.4 in /opt/conda/lib/python3.10/site-packages (from jsonschema>=3.0->altair<6,>=4.0->streamlit) (0.35.1)\nRequirement already satisfied: rpds-py>=0.7.1 in /opt/conda/lib/python3.10/site-packages (from jsonschema>=3.0->altair<6,>=4.0->streamlit) (0.18.1)\nRequirement already satisfied: six>=1.5 in /opt/conda/lib/python3.10/site-packages (from python-dateutil>=2.8.2->pandas<3,>=1.4.0->streamlit) (1.16.0)\nRequirement already satisfied: mpmath>=0.19 in /opt/conda/lib/python3.10/site-packages (from sympy->torch>=1.11.0->sentence-transformers) (1.3.0)\nRequirement already satisfied: pyasn1<0.7.0,>=0.4.6 in /opt/conda/lib/python3.10/site-packages (from pyasn1-modules>=0.2.1->google-auth!=2.24.0,!=2.25.0,<3.0.0,>=2.14.1->google-ai-generativelanguage<0.7.0,>=0.6.16->langchain-google-genai) (0.6.0)\nRequirement already satisfied: exceptiongroup>=1.0.2 in /opt/conda/lib/python3.10/site-packages (from anyio->httpx<1,>=0.23.0->langsmith<0.4,>=0.1.17->langchain) (1.2.0)\nDownloading pyngrok-7.2.5-py3-none-any.whl (23 kB)\nDownloading faiss_cpu-1.10.0-cp310-cp310-manylinux_2_28_x86_64.whl (30.7 MB)\n\u001b[2K   \u001b[90m━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━\u001b[0m \u001b[32m30.7/30.7 MB\u001b[0m \u001b[31m54.1 MB/s\u001b[0m eta \u001b[36m0:00:00\u001b[0m:00:01\u001b[0m00:01\u001b[0m\n\u001b[?25hDownloading sentence_transformers-4.1.0-py3-none-any.whl (345 kB)\n\u001b[2K   \u001b[90m━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━\u001b[0m \u001b[32m345.7/345.7 kB\u001b[0m \u001b[31m17.0 MB/s\u001b[0m eta \u001b[36m0:00:00\u001b[0m\n\u001b[?25hInstalling collected packages: pyngrok, faiss-cpu, sentence-transformers\nSuccessfully installed faiss-cpu-1.10.0 pyngrok-7.2.5 sentence-transformers-4.1.0\n","output_type":"stream"}],"execution_count":16},{"cell_type":"code","source":"import os\nos.environ[\"GOOGLE_API_KEY\"] = \"my_day1_secret_access_key\"  # Replace this with your key","metadata":{"trusted":true,"execution":{"iopub.status.busy":"2025-04-25T12:53:12.417725Z","iopub.execute_input":"2025-04-25T12:53:12.418124Z","iopub.status.idle":"2025-04-25T12:53:12.423289Z","shell.execute_reply.started":"2025-04-25T12:53:12.418085Z","shell.execute_reply":"2025-04-25T12:53:12.422214Z"}},"outputs":[],"execution_count":17},{"cell_type":"code","source":"pipeline_code = \"\"\"\nfrom langchain.vectorstores import FAISS\nfrom langchain.embeddings import HuggingFaceEmbeddings\nfrom langchain.prompts import PromptTemplate\nfrom langchain.chains import RetrievalQA\nfrom langchain_google_genai import ChatGoogleGenerativeAI\nimport os\n\nos.environ[\"GOOGLE_API_KEY\"] = os.getenv(\"GOOGLE_API_KEY\", \"my_day1_secret_access_key\")\n\ndb_faiss_path = \"faiss_index\"\nvectorstore = FAISS.load_local(db_faiss_path, HuggingFaceEmbeddings(model_name=\"all-MiniLM-L6-v2\"))\n\ncustom_prompt = PromptTemplate(\n    input_variables=[\"context\", \"question\"],\n    template=\\\"\\\"\\\"You are a research assistant. Based on the following context, answer the question.\n\nContext:\n{context}\n\nQuestion:\n{question}\n\nAnswer:\\\"\\\"\\\"\n)\n\nllm = ChatGoogleGenerativeAI(model=\"gemini-pro\", temperature=0.3)\n\nrag_pipeline = RetrievalQA.from_chain_type(\n    llm=llm,\n    retriever=vectorstore.as_retriever(),\n    chain_type=\"stuff\",\n    chain_type_kwargs={\"prompt\": custom_prompt}\n)\n\ndef get_rag_response(user_query):\n    return rag_pipeline.run(user_query)\n\"\"\"\n\nwith open(\"my_rag_pipeline.py\", \"w\") as f:\n    f.write(pipeline_code)\n","metadata":{"trusted":true,"execution":{"iopub.status.busy":"2025-04-25T12:54:07.348937Z","iopub.execute_input":"2025-04-25T12:54:07.349335Z","iopub.status.idle":"2025-04-25T12:54:07.355671Z","shell.execute_reply.started":"2025-04-25T12:54:07.349291Z","shell.execute_reply":"2025-04-25T12:54:07.354420Z"}},"outputs":[],"execution_count":18},{"cell_type":"code","source":"streamlit_code = \"\"\"\nimport streamlit as st\nfrom my_rag_pipeline import get_rag_response\n\nst.set_page_config(page_title=\"GenAI Insights\", page_icon=\"🧠\")\nst.title(\"🧠 GenAI Insights for Mental Health\")\nst.subheader(\"A Demo Interface for RAG-based Discovery\")\n\nuser_query = st.text_input(\"Enter your query (e.g., latest drugs for depression):\")\n\nif user_query:\n    with st.spinner(f\"Searching for: {user_query}\"):\n        response = get_rag_response(user_query)\n        st.success(\"🔍 Gemini 2.0 RAG Response:\")\n        st.markdown(response)\n\"\"\"\n\nwith open(\"app.py\", \"w\") as f:\n    f.write(streamlit_code)\n","metadata":{"trusted":true,"execution":{"iopub.status.busy":"2025-04-25T12:54:55.959442Z","iopub.execute_input":"2025-04-25T12:54:55.959863Z","iopub.status.idle":"2025-04-25T12:54:55.965692Z","shell.execute_reply.started":"2025-04-25T12:54:55.959829Z","shell.execute_reply":"2025-04-25T12:54:55.964444Z"}},"outputs":[],"execution_count":19},{"cell_type":"code","source":"!pip install streamlit pyngrok --quiet","metadata":{"trusted":true,"execution":{"iopub.status.busy":"2025-04-25T14:16:54.007938Z","iopub.execute_input":"2025-04-25T14:16:54.009007Z","iopub.status.idle":"2025-04-25T14:17:04.359648Z","shell.execute_reply.started":"2025-04-25T14:16:54.008958Z","shell.execute_reply":"2025-04-25T14:17:04.358056Z"}},"outputs":[],"execution_count":7},{"cell_type":"markdown","source":"##### Step 2: Authenticate Ngrok","metadata":{}},{"cell_type":"code","source":"\nfrom pyngrok import ngrok\nimport threading\nimport time\n\n\n# Start ngrok tunnel\nngrok.set_auth_token(\"2wDwhQ0JEKxzINUypc4jWhWXUH7_3rNDgaPjvK8ABk6RJjHuF\") ","metadata":{"trusted":true,"execution":{"iopub.status.busy":"2025-04-25T14:17:04.362602Z","iopub.execute_input":"2025-04-25T14:17:04.363144Z","iopub.status.idle":"2025-04-25T14:17:04.396100Z","shell.execute_reply.started":"2025-04-25T14:17:04.363091Z","shell.execute_reply":"2025-04-25T14:17:04.395070Z"}},"outputs":[],"execution_count":8},{"cell_type":"markdown","source":"##### Step 3: Write Your Streamlit App to a File\n\nHere’s a basic Streamlit interface calling a mock function (you’ll later replace get_rag_response with your Phase 4 RAG pipeline):","metadata":{}},{"cell_type":"code","source":"%%writefile app.py\nimport streamlit as st\n\n# Temporary mock function for testing\ndef get_rag_response(query):\n    return f\"🔍 You asked: {query}\\n\\n💡 This is a placeholder response from the GenAI Mental Health RAG system.\"\n\nst.set_page_config(page_title=\"GenAI Insights\", page_icon=\"🧠\")\nst.title(\"🧠 GenAI Insights for Mental Health\")\nst.subheader(\"A Demo Interface for RAG-based Discovery\")\n\nuser_query = st.text_input(\"Enter your query (e.g., latest drugs for depression):\")\n\nif user_query:\n    with st.spinner(\"Generating response...\"):\n        response = get_rag_response(user_query)\n        st.success(\"Response:\")\n        st.markdown(response)\n","metadata":{"trusted":true,"execution":{"iopub.status.busy":"2025-04-25T14:17:04.397584Z","iopub.execute_input":"2025-04-25T14:17:04.398059Z","iopub.status.idle":"2025-04-25T14:17:04.422479Z","shell.execute_reply.started":"2025-04-25T14:17:04.398012Z","shell.execute_reply":"2025-04-25T14:17:04.420974Z"}},"outputs":[{"name":"stdout","text":"Writing app.py\n","output_type":"stream"}],"execution_count":9},{"cell_type":"markdown","source":"##### Step 4: Launch Streamlit + Ngrok Tunnel\n\nThis code will start Streamlit and expose it with Ngrok:","metadata":{}},{"cell_type":"code","source":"import threading\nimport time\nfrom pyngrok import ngrok\n\n# Start Streamlit in a background thread\ndef run_streamlit():\n    !streamlit run app.py --server.port 8501 > /dev/null 2>&1\n\nthread = threading.Thread(target=run_streamlit)\nthread.start()\n\n# Wait a bit for the app to boot up\ntime.sleep(5)\n\n# Expose the app on port 8501 via ngrok\npublic_url = ngrok.connect(8501)\nprint(f\"🔗 App is live at: {public_url}\")\n","metadata":{"trusted":true,"execution":{"iopub.status.busy":"2025-04-25T14:17:04.424675Z","iopub.execute_input":"2025-04-25T14:17:04.425058Z","iopub.status.idle":"2025-04-25T14:17:09.565216Z","shell.execute_reply.started":"2025-04-25T14:17:04.425023Z","shell.execute_reply":"2025-04-25T14:17:09.564035Z"}},"outputs":[{"name":"stdout","text":"🔗 App is live at: NgrokTunnel: \"https://abe9-35-204-200-211.ngrok-free.app\" -> \"http://localhost:8501\"\n","output_type":"stream"}],"execution_count":10},{"cell_type":"code","source":"!pip install pyngrok","metadata":{"trusted":true,"execution":{"iopub.status.busy":"2025-04-25T14:03:28.025097Z","iopub.execute_input":"2025-04-25T14:03:28.025487Z","iopub.status.idle":"2025-04-25T14:03:38.556940Z","shell.execute_reply.started":"2025-04-25T14:03:28.025453Z","shell.execute_reply":"2025-04-25T14:03:38.555438Z"}},"outputs":[{"name":"stdout","text":"Collecting pyngrok\n  Downloading pyngrok-7.2.5-py3-none-any.whl.metadata (8.9 kB)\nRequirement already satisfied: PyYAML>=5.1 in /opt/conda/lib/python3.10/site-packages (from pyngrok) (6.0.2)\nDownloading pyngrok-7.2.5-py3-none-any.whl (23 kB)\nInstalling collected packages: pyngrok\nSuccessfully installed pyngrok-7.2.5\n","output_type":"stream"}],"execution_count":3},{"cell_type":"code","source":"import streamlit as st\n\n# Import your RAG pipeline setup\nfrom my_rag_pipeline import get_rag_response  # you create this in a separate file\n\nst.set_page_config(page_title=\"GenAI Insights\", page_icon=\"🧠\")\nst.title(\"🧠 GenAI Insights for Mental Health\")\nst.subheader(\"A Demo Interface for RAG-based Discovery\")\n\nuser_query = st.text_input(\"Enter your query (e.g., latest drugs for depression):\")\n\nif user_query:\n    with st.spinner(f\"Searching for: {user_query}\"):\n        response = get_rag_response(user_query)\n        st.success(\"🔍 Gemini 2.0 RAG Response:\")\n        st.markdown(response)\n","metadata":{"trusted":true,"execution":{"iopub.status.busy":"2025-04-22T14:14:52.316714Z","iopub.execute_input":"2025-04-22T14:14:52.317128Z","iopub.status.idle":"2025-04-22T14:14:53.623604Z","shell.execute_reply.started":"2025-04-22T14:14:52.317090Z","shell.execute_reply":"2025-04-22T14:14:53.622126Z"}},"outputs":[{"traceback":["\u001b[0;31m---------------------------------------------------------------------------\u001b[0m","\u001b[0;31mModuleNotFoundError\u001b[0m                       Traceback (most recent call last)","Cell \u001b[0;32mIn[36], line 4\u001b[0m\n\u001b[1;32m      1\u001b[0m \u001b[38;5;28;01mimport\u001b[39;00m \u001b[38;5;21;01mstreamlit\u001b[39;00m \u001b[38;5;28;01mas\u001b[39;00m \u001b[38;5;21;01mst\u001b[39;00m\n\u001b[1;32m      3\u001b[0m \u001b[38;5;66;03m# Import your RAG pipeline setup\u001b[39;00m\n\u001b[0;32m----> 4\u001b[0m \u001b[38;5;28;01mfrom\u001b[39;00m \u001b[38;5;21;01mmy_rag_pipeline\u001b[39;00m \u001b[38;5;28;01mimport\u001b[39;00m get_rag_response  \u001b[38;5;66;03m# you create this in a separate file\u001b[39;00m\n\u001b[1;32m      6\u001b[0m st\u001b[38;5;241m.\u001b[39mset_page_config(page_title\u001b[38;5;241m=\u001b[39m\u001b[38;5;124m\"\u001b[39m\u001b[38;5;124mGenAI Insights\u001b[39m\u001b[38;5;124m\"\u001b[39m, page_icon\u001b[38;5;241m=\u001b[39m\u001b[38;5;124m\"\u001b[39m\u001b[38;5;124m🧠\u001b[39m\u001b[38;5;124m\"\u001b[39m)\n\u001b[1;32m      7\u001b[0m st\u001b[38;5;241m.\u001b[39mtitle(\u001b[38;5;124m\"\u001b[39m\u001b[38;5;124m🧠 GenAI Insights for Mental Health\u001b[39m\u001b[38;5;124m\"\u001b[39m)\n","\u001b[0;31mModuleNotFoundError\u001b[0m: No module named 'my_rag_pipeline'"],"ename":"ModuleNotFoundError","evalue":"No module named 'my_rag_pipeline'","output_type":"error"}],"execution_count":36},{"cell_type":"code","source":"import os\nprint(os.listdir('/kaggle/working'))","metadata":{"trusted":true,"execution":{"iopub.status.busy":"2025-04-22T14:22:54.769510Z","iopub.execute_input":"2025-04-22T14:22:54.770479Z","iopub.status.idle":"2025-04-22T14:22:54.775663Z","shell.execute_reply.started":"2025-04-22T14:22:54.770440Z","shell.execute_reply":"2025-04-22T14:22:54.774724Z"}},"outputs":[{"name":"stdout","text":"['.virtual_documents', 'Phase4_RAG_Evaluation_Results.csv']\n","output_type":"stream"}],"execution_count":38},{"cell_type":"code","source":"from docx import Document\nfrom docx.shared import Inches\n\n# Create a new Word document\ndoc = Document()\n\n# Title\ndoc.add_heading('ETL Data Engineering Project Framework for WHITEOLIVE CHRISTIAN ASSEMBLY', 0)\n\n# Section 1: Introduction\ndoc.add_heading('1. Introduction', level=1)\ndoc.add_paragraph(\n    \"WHITEOLIVE CHRISTIAN ASSEMBLY is a faith-based organization that has been in existence for over eight years. \"\n    \"It operates through various units, manages social media platforms, conducts both physical and online services, \"\n    \"and has a vision for expansion. This document outlines a robust and scalable ETL data pipeline framework \"\n    \"to support data-driven decision-making.\"\n)\n\n# Section 2: Project Objectives\ndoc.add_heading('2. Project Objectives', level=1)\ndoc.add_paragraph(\n    \"- Design and implement a customized ETL pipeline for structured and unstructured data.\\n\"\n    \"- Integrate data from various internal and external sources.\\n\"\n    \"- Enable scalability, automation, and reliable orchestration of workflows.\\n\"\n    \"- Deliver clean, consistent, and analyzable data to a central repository or data mart.\"\n)\n\n# Section 3: Stakeholder Engagement & Requirements Gathering\ndoc.add_heading('3. Stakeholder Engagement & Requirements Gathering', level=1)\ndoc.add_paragraph(\n    \"- Conduct interviews and discovery sessions with unit leaders and administrative heads.\\n\"\n    \"- Document current data management practices, data silos, and manual processes.\\n\"\n    \"- Identify pain points, data gaps, and reporting requirements.\\n\"\n    \"- Define key performance indicators (KPIs) and goals for the ETL pipeline.\"\n)\n\n# Section 4: Environment Setup & Tool Selection Strategy\ndoc.add_heading('4. Environment Setup & Tool Selection Strategy', level=1)\ndoc.add_paragraph(\n    \"- Select suitable development, staging, and production environments (e.g., local Docker, AWS/GCP/Azure).\\n\"\n    \"- Determine tools based on scalability, cost, and ease of use (e.g., Apache Airflow, dbt, PostgreSQL).\\n\"\n    \"- Establish version control, CI/CD workflows, and monitoring strategies.\\n\"\n    \"- Provision cloud infrastructure with flexibility for scale-up/down.\"\n)\n\n# Section 5: Data Sources to be Integrated\ndoc.add_heading('5. Data Sources to be Integrated', level=1)\ndoc.add_paragraph(\n    \"The following data sources are expected to be integrated into the pipeline:\"\n)\ndoc.add_paragraph(\n    \"- Church Units and Operational Records\\n\"\n    \"   * Type: Internal Operational Data\\n\"\n    \"   * Source: Google Sheets, Excel Files, Paper Records\\n\"\n    \"   * Access Format: Manual Upload, Shared Drive Access\\n\\n\"\n    \"- Social Media Platforms (Instagram, YouTube, X, WhatsApp)\\n\"\n    \"   * Type: External Engagement Data\\n\"\n    \"   * Source: Platform APIs and Analytics Dashboards\\n\"\n    \"   * Access Format: API Access, CSV Exports, Admin Login\\n\\n\"\n    \"- Zoom Services Attendance\\n\"\n    \"   * Type: Attendance Logs\\n\"\n    \"   * Source: Zoom API or Admin Dashboard\\n\"\n    \"   * Access Format: API, Manual CSV Export\\n\\n\"\n    \"- Donation and Giving Platforms\\n\"\n    \"   * Type: Financial Data\\n\"\n    \"   * Source: Bank Statements, Giving Platforms\\n\"\n    \"   * Access Format: Manual Upload, API Access\\n\\n\"\n    \"- Events & Media Outreach Records\\n\"\n    \"   * Type: Event Registrations, Media Downloads\\n\"\n    \"   * Source: EventBrite, Google Forms, Website Logs\\n\"\n    \"   * Access Format: Manual Export, Google Drive\"\n)\n\n# Section 6: Pipeline Architecture Overview\ndoc.add_heading('6. Pipeline Architecture Overview', level=1)\ndoc.add_paragraph(\n    \"- Extraction: Scheduled/API-based extraction from source systems.\\n\"\n    \"- Transformation: Cleaning, validation, enrichment using dbt/Python.\\n\"\n    \"- Loading: Push to a centralized Data Mart (PostgreSQL/BigQuery).\\n\"\n    \"- Orchestration: Apache Airflow/Prefect for task scheduling.\\n\"\n    \"- Monitoring: Alerting on failures and performance via Slack/Email.\"\n)\n\n# Section 7: Design Pattern and Workflow\ndoc.add_heading('7. Design Pattern and Workflow', level=1)\ndoc.add_paragraph(\n    \"- Modular ETL design using micro-batch processing.\\n\"\n    \"- Task orchestration through DAGs (Directed Acyclic Graphs).\\n\"\n    \"- Retry policies, idempotent processing, logging.\\n\"\n    \"- Staging and transformation layers to ensure clean data delivery.\"\n)\n\n# Section 8: Data Storage and Data Mart\ndoc.add_heading('8. Data Storage and Data Mart', level=1)\ndoc.add_paragraph(\n    \"- Use cloud-based storage (e.g., Amazon S3 or GCS) for raw and intermediate data.\\n\"\n    \"- Implement a centralized Data Mart for reporting and dashboarding.\\n\"\n    \"- Normalize and aggregate data for efficient analytics.\"\n)\n\n# Section 9: Automation and Scaling Strategy\ndoc.add_heading('9. Automation and Scaling Strategy', level=1)\ndoc.add_paragraph(\n    \"- Use cloud-native orchestration tools (e.g., Airflow Cloud, AWS Step Functions).\\n\"\n    \"- Implement autoscaling for extraction and transformation jobs.\\n\"\n    \"- Schedule jobs based on data arrival or periodic intervals.\\n\"\n    \"- Containerize the pipeline using Docker for portability.\"\n)\n\n# Section 10: Risk Management & Best Practices\ndoc.add_heading('10. Risk Management & Best Practices', level=1)\ndoc.add_paragraph(\n    \"- Backup and disaster recovery for critical data.\\n\"\n    \"- Data validation and schema checks at every stage.\\n\"\n    \"- Maintain audit trails and metadata logging.\\n\"\n    \"- Use access controls and encryption for sensitive data.\"\n)\n\n# Save the document\ndoc_path = \"/mnt/data/WhiteOlive_ETL_Framework_Complete.docx\"\ndoc.save(doc_path)\n\ndoc_path\n","metadata":{"trusted":true},"outputs":[],"execution_count":null},{"cell_type":"code","source":"!pip install docx","metadata":{"trusted":true,"execution":{"iopub.status.busy":"2025-04-22T16:40:39.029259Z","iopub.execute_input":"2025-04-22T16:40:39.029595Z","iopub.status.idle":"2025-04-22T16:40:53.767196Z","shell.execute_reply.started":"2025-04-22T16:40:39.029561Z","shell.execute_reply":"2025-04-22T16:40:53.765006Z"}},"outputs":[{"name":"stdout","text":"Collecting docx\n  Downloading docx-0.2.4.tar.gz (54 kB)\n\u001b[2K     \u001b[90m━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━\u001b[0m \u001b[32m54.9/54.9 kB\u001b[0m \u001b[31m1.7 MB/s\u001b[0m eta \u001b[36m0:00:00\u001b[0m\n\u001b[?25h  Preparing metadata (setup.py) ... \u001b[?25ldone\n\u001b[?25hRequirement already satisfied: lxml in /opt/conda/lib/python3.10/site-packages (from docx) (5.3.0)\nRequirement already satisfied: Pillow>=2.0 in /opt/conda/lib/python3.10/site-packages (from docx) (10.3.0)\nBuilding wheels for collected packages: docx\n  Building wheel for docx (setup.py) ... \u001b[?25ldone\n\u001b[?25h  Created wheel for docx: filename=docx-0.2.4-py3-none-any.whl size=53895 sha256=0f973cc056771fb79edd0c4af444891150ce978557d027dee7c8c7bf0218ef39\n  Stored in directory: /root/.cache/pip/wheels/81/f5/1d/e09ba2c1907a43a4146d1189ae4733ca1a3bfe27ee39507767\nSuccessfully built docx\nInstalling collected packages: docx\nSuccessfully installed docx-0.2.4\n","output_type":"stream"}],"execution_count":1},{"cell_type":"code","source":"","metadata":{"trusted":true},"outputs":[],"execution_count":null}]}